111 min read

Part IV · Maintenance  ·  Estimated reading time 110 minutes  ·  Prerequisites: Chapters 2, 3, 16, 23

24. Nutrition and Metabolism

Energy, Nutrients, and the Biochemistry of Fuel

Part IV · Maintenance  ·  Estimated reading time 110 minutes  ·  Prerequisites: Chapters 2, 3, 16, 23


Case File 24 — "Two Metabolisms, One Kitchen Table"

Six months after her infarct, Amara Osei, 45, comes to a combined cardiology and endocrine clinic. Her daughter Nia Osei-Barrett, 24, comes with her — partly to translate, partly because she ran a marathon three weeks ago and has a question of her own.

The two of them are sitting at the same table, eating the same food, carrying the same genes. The food does something entirely different in each of them.

Amara. Height 5'5" (165 cm), weight 176 lb (80 kg), BMI 29.3.

Measurement Value Metabolic syndrome threshold (female)
Waist circumference 96 cm ≥ 88 cm
Triglycerides 244 mg/dL ≥ 150 mg/dL
HDL cholesterol 38 mg/dL < 50 mg/dL
Blood pressure 138/84 mm Hg, on treatment ≥ 130/85 or on treatment
Fasting plasma glucose 212 mg/dL (11.8 mmol/L) ≥ 100 mg/dL or on treatment
Hemoglobin A1c 7.4% (normal < 5.7%)
Fasting insulin 28 µU/mL (normal 2–12)

She meets all five criteria. Three are needed for the diagnosis.

Nia. Height 5'7" (170 cm), weight 128 lb (58 kg), BMI 20.1. Marathon finish 3:22:14 — a personal best by four minutes. Fasting glucose 84 mg/dL, HDL 71 mg/dL, triglycerides 62 mg/dL, blood pressure 108/66.

Her account of the race: "I was completely fine through mile 20. I was hitting 7:35s and it felt easy. Then somewhere in the twenty-first mile my legs turned into concrete. I wasn't out of breath. My heart rate actually went down. I just could not make my legs go. I finished the last five miles at 8:40 pace and I was trying as hard as I have ever tried in my life."

Three questions.

  1. Amara and Nia both absorb glucose from the same meal into the same portal vein. Trace what happens to that glucose in each body and explain, in mechanistic terms, why the same molecule produces a fasting glucose of 212 in one and 84 in the other.
  2. What physically ran out at mile 21? Why does that particular point in a marathon happen to almost everyone who races one, regardless of talent — and why did Nia's heart rate fall rather than rise?
  3. Amara is told that a single 40-minute walk will improve her insulin sensitivity for the next two days, before she has lost a single pound. How can exercise lower blood glucose in a person whose insulin does not work?

Learning Objectives

By the end of this chapter you should be able to:

  1. Name the six classes of nutrients and state the energy yield per gram of carbohydrate, protein, fat, and alcohol.
  2. Distinguish essential from nonessential amino acids and fatty acids, and explain what "essential" actually means.
  3. Interpret the dietary reference intakes (EAR, RDA, AI, UL) and say what each is for.
  4. Explain from first principles why fat-soluble vitamins accumulate and water-soluble ones generally do not — and name the exceptions.
  5. Define anabolism, catabolism, oxidation, and reduction, and state the role of NAD⁺ and FAD.
  6. Trace glucose through glycolysis, the citric acid cycle, and oxidative phosphorylation, and account for the ATP produced at each stage.
  7. Explain chemiosmosis and why the mitochondrial inner membrane must be impermeable to protons.
  8. Contrast glycogenesis, glycogenolysis, and gluconeogenesis, and explain why liver glycogen serves the blood while muscle glycogen serves only the muscle.
  9. Describe beta-oxidation, ketogenesis, lipogenesis, and lipolysis, and explain why fatty acids cannot be converted into glucose.
  10. Identify the four lipoproteins, their cargo and routes, and say what makes LDL "bad" and HDL "good" mechanistically.
  11. Describe transamination, oxidative deamination, and the urea cycle, and explain why protein is the fuel of last resort.
  12. Draw the absorptive and postabsorptive states as organ-by-organ substrate flows and name the hormone controlling each.
  13. Define BMR and total energy expenditure and list the four components of the latter.
  14. Interpret a respiratory exchange ratio and say what fuel mix it implies.
  15. Describe the regulation of food intake by leptin, ghrelin, insulin, and the arcuate nucleus, and explain why body weight is defended.
  16. Explain thermoregulation: heat production, the four routes of heat loss, the hypothalamic thermostat, fever, hyperthermia, and hypothermia.
  17. Explain insulin resistance as a failure of hormonal switching, and describe the insulin-independent, contraction-activated pathway for GLUT4 translocation.

24.1 Nutrients: What the Body Actually Requires

A nutrient is any substance in food used by the body to promote growth, maintenance, or repair. There are six classes, and the division that matters is not chemical but arithmetical: three of them yield energy and three do not.

Class Energy? Yield Principal role
Carbohydrate Yes 4 kcal/g The preferred fuel; the only fuel the brain and red cells can use without adaptation
Lipid Yes 9 kcal/g Energy storage, membranes, steroid hormones, insulation, fat-soluble vitamin transport
Protein Yes 4 kcal/g Structure, enzymes, transport, immunity — used as fuel only under duress
Vitamins No Coenzymes and regulators; needed in milligram or microgram quantities
Minerals No Structure (bone), electrolytes, enzyme cofactors
Water No 50–60% of body mass; the solvent for everything

(Alcohol yields 7 kcal/g and belongs in no class — it is not a nutrient, because no body process requires it, but it is unavoidably a fuel.)

Note that fat carries more than twice the energy per gram of the other two. That is not arbitrary: fatty acid carbons are highly reduced — heavily loaded with hydrogen — and the energy released by oxidation is proportional to how much hydrogen there is to strip off. Carbohydrate carbons already carry oxygen and are therefore partly oxidized before you start. The 9-versus-4 ratio is a statement about chemistry, and it is exactly why the body stores long-term energy as fat: storing 100,000 kcal as glycogen, which also binds about 3 g of water per gram, would add well over 60 kg of body mass.

Essential and nonessential

Essential does not mean important. It means the body cannot synthesize it, so it must be eaten. Nonessential nutrients are no less necessary — you simply make them yourself.

Nine essential amino acids: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine. A complete protein supplies all nine in adequate proportion (animal proteins, soy, quinoa). Most single plant proteins are limiting in one or two — grains in lysine, legumes in methionine — which is why grain-and-legume combinations recur independently in cuisines across the world. They need not be eaten in the same meal; the body maintains a free amino acid pool over roughly a day.

Two essential fatty acids: linoleic acid (18:2, omega-6) and α-linolenic acid (18:3, omega-3). Humans lack the desaturases to place a double bond beyond carbon 9. From these two, the body makes arachidonic acid (and hence the prostaglandins of Chapter 23) and, inefficiently, EPA and DHA.

Fibre deserves separate mention because it is a carbohydrate that yields almost no energy and is nonetheless required. Insoluble fibre adds bulk and accelerates transit; soluble fibre forms gels that slow gastric emptying, blunt the postprandial glucose rise, and bind bile acids — which forces the liver to consume cholesterol making replacements. Recommended intake is 25–38 g/day; typical intake in the United States is about 15 g.

Dietary reference intakes

Term Definition Use
EAR (estimated average requirement) Meets the needs of 50% of a group Assessing populations; the basis for the RDA
RDA (recommended dietary allowance) EAR plus 2 standard deviations — meets the needs of 97–98% Planning individual intake
AI (adequate intake) An observed or estimated value used when data are insufficient for an EAR Where an RDA cannot be set
UL (tolerable upper intake level) Highest daily intake likely to pose no risk Judging supplements

The AMDRs (acceptable macronutrient distribution ranges) are 45–65% of energy from carbohydrate, 20–35% from fat, and 10–35% from protein — ranges wide enough to accommodate most of the world's traditional diets, which is the point.

What the evidence actually supports

Nutrition is the area of physiology most burdened by confident claims, so it is worth stating plainly what survives repeated testing:

  • Total energy balance governs body mass over time. No macronutrient composition repeals the first law of thermodynamics, though composition strongly affects satiety, adherence, and metabolic outcomes.
  • Food matrix matters as much as nutrient content. Whole fruit and fruit juice have similar sugar content and different effects, because fibre, structure, and the rate of gastric emptying determine the glucose and insulin trajectory.
  • Dietary patterns predict outcomes better than single nutrients. Patterns emphasizing vegetables, fruit, legumes, whole grains, nuts, fish, and unsaturated fats are associated with lower cardiovascular and all-cause mortality across many populations and designs.
  • Replacement, not removal, is what matters. "Reduce saturated fat" is meaningless until you say what replaces it. Replaced by polyunsaturated fat, cardiovascular risk falls; replaced by refined carbohydrate, it does not.
  • Sodium, added sugar, and alcohol have dose-related harms with reasonable evidence, and most people consume more of all three than they believe.

Check Your Understanding 24.1

  1. A gram of fat yields 9 kcal and a gram of carbohydrate 4. Explain the difference chemically.
  2. Why is it misleading to call nonessential amino acids "nonessential"?
  3. Vitamin D can be synthesized in skin from cholesterol under ultraviolet light. Is it a vitamin?
Show answers
  1. Energy released by oxidation is proportional to the number of C–H bonds available to be broken. Fatty acids are long hydrocarbon chains — maximally reduced, carrying hydrogen at nearly every carbon. Carbohydrate carbons already bear hydroxyl groups and are therefore partially oxidized before metabolism begins, so less energy remains to extract.
  2. Because they are just as necessary to the body; the word describes only whether they must appear in the diet. Several are also conditionally essential — the body's synthetic capacity can be outstripped in illness, prematurity, or rapid growth. Arginine and glutamine are the standard examples, and in phenylketonuria tyrosine becomes essential because the pathway that makes it is blocked.
  3. Strictly, no — a vitamin is by definition something the body cannot make. Vitamin D is a prohormone synthesized in skin and activated by liver and kidney, and it acts through a nuclear receptor like a steroid hormone (Chapters 5, 6, and 16). It is classified as a vitamin for historical reasons: it was discovered as a dietary deficiency disease, because most people at most latitudes in winter genuinely cannot make enough.

24.2 Vitamins and Minerals: Learn the Logic, Then the List

Why solubility determines everything

Two properties follow from whether a vitamin dissolves in fat or in water, and they explain nearly all of vitamin physiology.

Fat-soluble vitamins (A, D, E, K):

  • are absorbed with dietary fat, in micelles, requiring bile — so any cause of fat malabsorption causes deficiency in all four (Chapter 23);
  • travel in lipoproteins and are stored in liver and adipose tissue;
  • are not readily excreted, because the kidney filters plasma water and lipophilic molecules bound to carrier proteins are neither freely filtered nor easily lost;
  • therefore accumulate, and therefore can be toxic.

Water-soluble vitamins (B complex, C):

  • dissolve in plasma, are freely filtered at the glomerulus, and are excreted when in excess;
  • are not stored in quantity, so intake must be regular and deficiency develops in weeks to months;
  • are rarely toxic, because excess leaves in the urine.

Two exceptions prove the rule. Vitamin B₁₂ behaves like a fat-soluble vitamin: it is protein-bound, requires intrinsic factor, recirculates enterohepatically, and is stored in the liver in a 3–5 year supply — which is why pernicious anemia takes years to appear. And vitamin B₆ and niacin have genuine toxicity at supplement doses (sensory neuropathy and flushing/hepatotoxicity respectively), because their excretion capacity can be exceeded.

Vitamin Key function Deficiency Toxicity
A (retinol) 11-cis-retinal for vision; epithelial differentiation; immunity Night blindness → xerophthalmia; the leading preventable childhood blindness worldwide Liver damage, intracranial hypertension, teratogenic
D (calciferol) Calcitriol: intestinal Ca²⁺ absorption, bone mineralization Rickets (children), osteomalacia (adults) Hypercalcemia, nephrocalcinosis
E (tocopherol) Chain-breaking antioxidant of membrane lipids Rare: hemolysis, peripheral neuropathy Bleeding at very high doses (antagonizes K)
K (phylloquinone) γ-carboxylation of factors II, VII, IX, X, protein C/S, osteocalcin Bleeding; hemorrhagic disease of the newborn Low
B₁ thiamine TPP: pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, transketolase Beriberi; Wernicke–Korsakoff syndrome None known
B₂ riboflavin FAD, FMN Angular cheilitis, glossitis None known
B₃ niacin NAD⁺, NADP⁺ Pellagra — dermatitis, diarrhea, dementia, death Flushing; hepatotoxicity at high dose
B₅ pantothenate Coenzyme A Rare None
B₆ pyridoxine PLP: transamination, heme synthesis Sideroblastic anemia, neuropathy, seizures Sensory neuropathy
B₇ biotin Carboxylases (incl. pyruvate carboxylase) Rare; raw egg white binds it None
B₉ folate One-carbon transfer; thymidylate synthesis Megaloblastic anemia; neural tube defects Masks B₁₂ deficiency
B₁₂ cobalamin Methionine synthase; methylmalonyl-CoA mutase Megaloblastic anemia + subacute combined degeneration None known
C ascorbate Hydroxylation of proline and lysine in collagen; iron absorption; antioxidant Scurvy — bleeding gums, poor wound healing, perifollicular hemorrhage Diarrhea, oxalate stones

Minerals

Major minerals (required at more than 100 mg/day): calcium, phosphorus, potassium, sulfur, sodium, chloride, magnesium. Trace minerals (less than 100 mg/day): iron, zinc, copper, iodine, selenium, manganese, fluoride, chromium, molybdenum, cobalt.

Their functions cluster into three: structural (calcium and phosphorus in hydroxyapatite), electrochemical (Na⁺, K⁺, Cl⁻, Ca²⁺ — the ionic basis of every action potential and contraction in this book), and catalytic (iron in heme and cytochromes; zinc in over 300 enzymes; iodine in thyroid hormone; selenium in glutathione peroxidase).

Two are worth remembering as absorption problems rather than intake problems. Iron is absorbed in the duodenum at a rate set by hepcidin, and heme iron from meat is absorbed 3–5 times more efficiently than non-heme iron from plants — which is why Amara's iron deficiency from Chapter 23 will not be corrected quickly by diet alone. Calcium absorption depends on calcitriol and falls sharply with age.

Clinical Connection · Four Deficiency Syndromes That Teach the Biochemistry

Thiamine (B₁) and Wernicke encephalopathy. Thiamine pyrophosphate is a required cofactor for pyruvate dehydrogenase and α-ketoglutarate dehydrogenase — the two gateways into and through the citric acid cycle. Without it, cells cannot oxidize glucose aerobically, and the tissue that suffers first is the one with the highest glucose demand and no fuel alternative: the brain. Hence confusion, ophthalmoplegia, and ataxia. The critical practical point follows from the mechanism: giving glucose to a thiamine-deficient patient consumes the last of the cofactor and can precipitate the syndrome. Thiamine goes in first.

Niacin and pellagra. Niacin is the precursor of NAD⁺ and NADP⁺, the electron carriers of essentially every oxidation in the body. Deficiency therefore hits the tissues with the highest turnover: skin (dermatitis, classically in sun-exposed areas), gut epithelium (diarrhea), and brain (dementia). The four Ds — dermatitis, diarrhea, dementia, death — are a readout of which tissues divide fastest.

Vitamin C and scurvy. Ascorbate is the cofactor that hydroxylates proline and lysine in procollagen, and hydroxylation is what allows the collagen triple helix to cross-link and hold tension. Without it, newly made collagen is defective, and every structure that depends on recent collagen turnover fails: gums bleed, wounds reopen, capillaries leak, and old scars come apart. Scurvy is a disease of collagen quality, which is why it looks like a bleeding disorder with normal platelets and normal clotting times.

Vitamin B₁₂ and subacute combined degeneration. B₁₂ is required by methionine synthase, which regenerates methionine and, in doing so, releases folate from a metabolically trapped form. Deficiency therefore produces a folate-type megaloblastic anemia that folate supplementation will partly correct — while the second B₁₂-dependent enzyme, methylmalonyl-CoA mutase, remains blocked, and abnormal fatty acids are incorporated into myelin. Giving folate alone corrects the blood count and lets irreversible spinal cord degeneration proceed silently. This is why an unexplained macrocytic anemia is never treated with folate until B₁₂ has been measured.

Check Your Understanding 24.2

  1. A patient with long-standing biliary obstruction develops easy bruising and a prolonged prothrombin time, but a normal platelet count. Explain.
  2. Why can a person survive years without dietary B₁₂ but only weeks without dietary thiamine?
  3. Explain why vitamin A supplements carry a pregnancy warning and vitamin C supplements do not.
Show answers
  1. Bile is required to form the micelles that carry fat-soluble vitamins across the unstirred water layer. Obstruction therefore causes vitamin K deficiency, and vitamin K is the cofactor for γ-carboxylation of clotting factors II, VII, IX, and X — without which those factors are synthesized but cannot bind calcium or assemble on phospholipid surfaces. Platelets are unaffected, so the count is normal; the defect is in the coagulation cascade, so the prothrombin time is prolonged. Note that this also distinguishes the coagulopathy of obstruction (correctable with parenteral vitamin K) from that of hepatocellular failure (not correctable, because the factors themselves cannot be made).
  2. B₁₂ is stored in the liver in a 3–5 year supply and is efficiently recycled through the enterohepatic circulation; it behaves, uniquely among water-soluble vitamins, like a fat-soluble one. Thiamine is a true water-soluble vitamin with minimal storage (roughly 30 mg total body content) and continuous urinary loss, and it is consumed in proportion to carbohydrate oxidation — so a high-carbohydrate intake accelerates depletion.
  3. Because vitamin A accumulates. Being fat-soluble it is stored in the liver and not readily excreted, so chronic intake above the upper limit raises tissue concentrations, and retinoids are potent regulators of gene expression during embryonic patterning — hence teratogenicity. Excess vitamin C, being water-soluble and freely filtered, is in the urine within hours; the worst it does is cause osmotic diarrhea on the way through and raise oxalate excretion.

24.3 The Vocabulary of Metabolism

Metabolism is the sum of all chemical reactions in the body. It has two directions:

  • Anabolism builds larger molecules from smaller ones. It consumes energy (endergonic) and usually proceeds by dehydration synthesis. Glycogen from glucose, protein from amino acids, triglyceride from fatty acids.
  • Catabolism breaks larger molecules into smaller ones, releasing energy (exergonic), usually by hydrolysis and oxidation.

The two run simultaneously in the same cell. What changes between the fed and fasted state is not whether they occur but which direction has the upper hand — and that balance is set almost entirely by hormones.

Oxidation, reduction, and the electron carriers

Oxidation is loss of electrons; reduction is gain. In biological systems electrons usually travel as hydrogen atoms (an electron plus a proton), so a molecule that loses hydrogen has been oxidized and one that gains hydrogen has been reduced. The two always happen together — there is no free electron in solution — hence redox reaction.

Catabolism is a controlled oxidation. Its purpose is to strip hydrogen (and thus electrons) from fuel molecules and hand them to carriers:

  • NAD⁺ (from niacin) accepts two electrons and one proton: NAD⁺ + 2H → NADH + H⁺.
  • FAD (from riboflavin) accepts two electrons and two protons: FAD + 2H → FADH₂.

These carriers are the currency of the whole system. A reduced carrier is a packet of transferable energy, and the entire architecture of aerobic metabolism exists to walk those electrons down a chain to oxygen while capturing the released energy as ATP.

ATP

ATP is the universal energy currency because its terminal phosphoanhydride bonds release a large, usable quantity of energy on hydrolysis — about 7.3 kcal/mol under standard conditions and closer to 12 kcal/mol under the concentrations actually found in a cell.

Two facts about ATP are more instructive than the structure:

  • The body's total ATP pool at any instant is only about 100 g. It is not a storage molecule; it is a transfer molecule, made and consumed within seconds.
  • A resting adult turns over roughly 50–75 kg of ATP per day, and far more during exercise. Each molecule is recycled hundreds of times daily.

Energy is transferred to work by phosphorylation — the transfer of a phosphate group from ATP to another molecule, which raises that molecule's energy and changes its conformation. There are two ways to make ATP:

  • Substrate-level phosphorylation: a phosphate is transferred directly from a high-energy substrate to ADP. Fast, oxygen-independent, and low-yield. It occurs in glycolysis and once in the citric acid cycle.
  • Oxidative phosphorylation: energy from electron transfer is used to pump protons across a membrane, and the resulting gradient drives ATP synthase. Slower to start, oxygen-dependent, and responsible for about 90% of the ATP you make.

24.4 Carbohydrate Metabolism

Glycolysis

Glycolysis splits one 6-carbon glucose into two 3-carbon pyruvates. It occurs in the cytosol, requires no oxygen, and is present in essentially every cell — including red blood cells, which have no mitochondria at all and depend on it entirely.

It has two halves. The energy investment phase spends 2 ATP: hexokinase (glucokinase in the liver) phosphorylates glucose to glucose-6-phosphate, trapping it in the cell, and phosphofructokinase-1 performs the committed, rate-limiting, allosterically regulated step. The energy payoff phase produces 4 ATP by substrate-level phosphorylation and 2 NADH.

Net per glucose: 2 ATP, 2 NADH, 2 pyruvate.

The fate of pyruvate

Four possibilities, and which one occurs tells you almost everything about the cell's situation:

  1. → Acetyl-CoA, by the pyruvate dehydrogenase complex, in the mitochondrion, when oxygen is available. This step also produces NADH and releases CO₂, and it is irreversible — a fact with enormous consequences, developed in §24.5.
  2. → Lactate, by lactate dehydrogenase, when NADH accumulates faster than mitochondria can reoxidize it. The purpose is not to make lactate; the purpose is to regenerate NAD⁺ so that glycolysis can continue. Lactate is not a waste product and not the cause of muscle soreness — it is a fuel, shuttled to heart, other muscle fibres, and the liver, where the Cori cycle converts it back to glucose.
  3. → Alanine, by transamination, for transport of both carbon and nitrogen to the liver.
  4. → Oxaloacetate, by pyruvate carboxylase, replenishing the citric acid cycle and feeding gluconeogenesis.

The citric acid cycle

In the mitochondrial matrix, acetyl-CoA (2 carbons) condenses with oxaloacetate (4 carbons) to form citrate (6 carbons). Eight reactions later, oxaloacetate is regenerated and two carbons have left as CO₂ — the CO₂ you exhale.

Per acetyl-CoA: 3 NADH, 1 FADH₂, 1 ATP (via GTP), 2 CO₂. Per glucose, double it.

The cycle produces almost no ATP directly. Its output is reduced electron carriers, and it is also the metabolic crossroads at which carbohydrate, fat, and protein converge — which is why Figure 24.1 is drawn the way it is.

Oxidative phosphorylation and chemiosmosis

The electron transport chain is four complexes plus two mobile carriers embedded in the inner mitochondrial membrane. NADH delivers electrons at complex I, FADH₂ at complex II; both pass them along a chain of carriers of progressively greater electron affinity, ending at complex IV, where four electrons, four protons, and one O₂ combine to make two H₂O. This is the only place oxygen is used in the entire body, and it is why you breathe.

As electrons move, complexes I, III, and IV pump protons from matrix into intermembrane space. Because the inner membrane is impermeable to protons, this creates an electrochemical gradient — the proton-motive force, roughly 200 mV. Protons can return to the matrix through only one route: ATP synthase, a rotary molecular motor. Their flow spins it, and the rotation drives the condensation of ADP and phosphate into ATP. This coupling of an electrochemical gradient to ATP synthesis is chemiosmosis — Peter Mitchell's idea, rejected for a decade and then awarded a Nobel Prize.

Its yield: about 2.5 ATP per NADH and 1.5 per FADH₂.

Thread 1 · Structure Determines Function

Chemiosmosis works for one structural reason: the inner mitochondrial membrane is impermeable to protons. Everything else follows. Because protons cannot leak back, pumping them creates a gradient; because the only return path is through ATP synthase, the gradient can do work. The membrane's impermeability is not a passive property — it is the mechanism.

Two natural experiments prove it. Brown adipose tissue deliberately punctures that impermeability with UCP1, and the mitochondrion instantly converts from an ATP factory into a heater (§24.9). And the poison 2,4-dinitrophenol does the same thing chemically and uncontrollably, with results discussed in the review section of this chapter.

The lesson generalizes beyond metabolism. When a structure's job is to prevent something, its importance is invisible until it fails — and the fastest way to understand what a barrier does is to find the case in which it is removed.

  ATP ACCOUNTING FROM ONE MOLECULE OF GLUCOSE
  ══════════════════════════════════════════════════════════════════════

  STAGE            LOCATION        DIRECT ATP    CARRIERS   ATP FROM
                                   (substrate-              CARRIERS
                                    level)                  (oxidative)
  ──────────────────────────────────────────────────────────────────────
  GLYCOLYSIS       cytosol         -2 invested   2 NADH*    2 x 1.5 = 3
  glucose→2 pyruvate               +4 produced              (or 2x2.5=5)
                                   ────────────
                                   NET  +2

  PYRUVATE →       mitochondrial       0         2 NADH     2 x 2.5 = 5
  ACETYL-CoA (x2)  matrix                        (+2 CO2)

  CITRIC ACID      mitochondrial      +2         6 NADH     6 x 2.5 = 15
  CYCLE (x2)       matrix           (via GTP)    2 FADH2    2 x 1.5 = 3
                                                 (+4 CO2)
  ──────────────────────────────────────────────────────────────────────
  TOTAL                              +4                     +26  (or 28)
                                            ═══════════════════════════
                                            GRAND TOTAL: 30-32 ATP

  * Cytosolic NADH cannot cross the inner membrane. It is handed over by
    a SHUTTLE, and which shuttle a tissue uses changes the yield:
      GLYCEROL PHOSPHATE shuttle (muscle, brain) → delivers as FADH2 → 1.5
      MALATE-ASPARTATE   shuttle (liver, heart)  → delivers as NADH  → 2.5
    This is the entire reason textbooks disagree about "36 vs 38 vs 32".

  ── EFFICIENCY ────────────────────────────────────────────────────────
     Complete oxidation of glucose releases      686 kcal/mol
     Captured as ATP: 32 x ~7.3 kcal/mol    =   ~234 kcal/mol
     EFFICIENCY  =  234 / 686  =  ~34%
     The other ~66% is released as HEAT — which is not waste. It is
     precisely what holds your core at 37 C (see 21.9).

  ── ANAEROBIC COMPARISON ──────────────────────────────────────────────
     glucose → 2 lactate    yields  2 ATP     (6% of the aerobic yield)
     ...but it is ~100x FASTER per unit time, needs no oxygen, and needs
     no mitochondria. Speed bought at the price of efficiency.

Figure 24.1 — Complete ATP accounting for the oxidation of one glucose molecule, with the shuttle systems that explain the differing totals in different textbooks.

Described: A four-row accounting table. Glycolysis, in the cytosol, invests two ATP and produces four for a net of two by substrate-level phosphorylation, plus two cytosolic NADH. The conversion of two pyruvates to two acetyl-CoA in the mitochondrial matrix yields no direct ATP but two NADH and two carbon dioxide, worth five ATP. Two turns of the citric acid cycle in the matrix yield two ATP through GTP, six NADH worth fifteen ATP, two FADH2 worth three ATP, and four carbon dioxide. Direct substrate-level ATP totals four; oxidative phosphorylation contributes twenty-six to twenty-eight, giving a grand total of thirty to thirty-two ATP. The range exists because cytosolic NADH cannot cross the inner mitochondrial membrane and must be handed over by a shuttle: the glycerol phosphate shuttle used by muscle and brain delivers electrons as FADH2 worth one and a half ATP each, while the malate-aspartate shuttle used by liver and heart delivers them as NADH worth two and a half each. On efficiency: complete oxidation of glucose releases 686 kilocalories per mole, of which roughly 234 are captured as ATP, an efficiency of about thirty-four percent; the remaining two-thirds is released as heat, which is not wasted but is what maintains core body temperature at thirty-seven degrees Celsius. For comparison, anaerobic conversion of glucose to two lactate yields only two ATP, about six percent of the aerobic yield, but proceeds roughly a hundred times faster per unit time and requires neither oxygen nor mitochondria — speed bought at the price of efficiency.

Storing and releasing glucose

Glycogenesis — glucose → glucose-6-phosphate → glucose-1-phosphate → UDP-glucose → glycogen, by glycogen synthase. Stimulated by insulin. Glycogen is a highly branched polymer, and the branching is functional: each branch end is a site where an enzyme can work, so a branched molecule can be dismantled at hundreds of points simultaneously.

Glycogenolysisglycogen phosphorylase cleaves glucose-1-phosphate from the branch ends. Stimulated by glucagon (liver) and epinephrine (liver and muscle).

Gluconeogenesis — synthesis of glucose from non-carbohydrate precursors: lactate (Cori cycle), glycerol from triglyceride, and glucogenic amino acids, especially alanine and glutamine. It occurs in the liver (~90%) and renal cortex (~10%), costs about 6 ATP equivalents per glucose, and requires four enzymes that bypass the three irreversible steps of glycolysis: pyruvate carboxylase, PEP carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase.

Predict This

Liver glycogen stores about 100 g of glucose; skeletal muscle stores about 400 g. Yet when your blood sugar falls, only the liver's 100 g can help you. Before reading on: what single enzyme must muscle be missing?

(Answer: glucose-6-phosphatase. Work out what its absence implies before you continue.)

Why liver glycogen serves the blood and muscle glycogen does not

Glycogenolysis in both tissues yields glucose-6-phosphate. A phosphorylated sugar carries a charge and cannot cross the plasma membrane — that is the whole reason hexokinase phosphorylates glucose on entry, to trap it.

The liver possesses glucose-6-phosphatase, which removes the phosphate and produces free glucose that diffuses out through GLUT2 into the blood. The liver is therefore an exporter: it maintains blood glucose for the rest of the body, especially the brain.

Skeletal muscle lacks glucose-6-phosphatase entirely. Its glucose-6-phosphate cannot leave; it can only enter glycolysis within that muscle fibre. Muscle glycogen is a private fuel depot for the cell that owns it, and it contributes nothing directly to blood glucose.

This is not a design flaw. Muscle mass is about 40% of body weight and can consume glucose at enormous rates; a muscle able to export glucose would compete with the brain for it during exercise. The distribution of a single enzyme enforces a priority ordering between organs. Note also that muscle contributes to blood glucose indirectly, by exporting lactate and alanine to the liver for gluconeogenesis — the Cori and glucose–alanine cycles. The carbon returns; it just takes the long way round, and the liver pays the ATP bill.

Check Your Understanding 24.4

  1. In von Gierke disease, glucose-6-phosphatase is deficient. Predict the fasting blood glucose, the liver size, and the blood lactate.
  2. A red blood cell has no mitochondria. What is its maximum ATP yield per glucose, and why is this arrangement acceptable for that particular cell?
  3. Why does the oxygen you breathe end up almost entirely in water rather than in CO₂?
Show answers
  1. Fasting hypoglycemia, often severe, because neither glycogenolysis nor gluconeogenesis can deliver free glucose to the blood — both pathways terminate at glucose-6-phosphate. Hepatomegaly, because glycogen accumulates in a liver that can break it down but cannot export the product. Elevated lactate, because accumulating glucose-6-phosphate is pushed forward through glycolysis to pyruvate and then lactate; patients often have a metabolic acidosis, along with hyperuricemia and hypertriglyceridemia from the same overflow.
  2. 2 ATP, from glycolysis alone, with pyruvate converted to lactate to regenerate NAD⁺. It is acceptable — indeed necessary — because a red cell's job is to carry oxygen, not to consume it. Mitochondria would burn the cargo. Losing the nucleus and mitochondria also frees internal volume for hemoglobin and gives the cell the deformability to squeeze through capillaries narrower than itself. Structure determining function, at the price of a 94% reduction in energy yield.
  3. Because oxygen's role is as the final electron acceptor at complex IV of the electron transport chain, where it combines with electrons and protons to form H₂O. The carbon dioxide you exhale comes from decarboxylation reactions — in the pyruvate dehydrogenase step and the citric acid cycle — whose oxygen atoms derive from the substrate and from water, not from inhaled O₂. Inhaled oxygen becomes exhaled water vapour, not exhaled carbon dioxide, which is one of the more surprising facts in metabolism.

24.5 Lipid Metabolism

Beta-oxidation

A fatty acid is activated in the cytosol to fatty acyl-CoA at a cost of 2 ATP equivalents, then carried into the mitochondrion by the carnitine shuttle. Carnitine palmitoyltransferase-1 (CPT-1) on the outer membrane is the rate-limiting step, and it is inhibited by malonyl-CoA, the first committed intermediate of fatty acid synthesis. That single inhibition is a beautiful piece of regulation: when the cell is building fat, the molecule it builds first physically closes the door to fat breakdown. The two opposing pathways cannot run at once.

Inside the matrix, beta-oxidation removes two carbons at a time in a repeating four-step cycle, each turn yielding 1 FADH₂, 1 NADH, and 1 acetyl-CoA.

Palmitate (C16) requires seven cycles: 8 acetyl-CoA, 7 NADH, 7 FADH₂. Feeding those into the citric acid cycle and electron transport chain gives roughly 106 ATP net — against 30–32 for glucose. That number is the 9-kcal-per-gram figure from §24.1, arrived at from the opposite direction.

Ketogenesis

Acetyl-CoA can enter the citric acid cycle only by condensing with oxaloacetate. In prolonged fasting, starvation, or uncontrolled diabetes, oxaloacetate is continuously siphoned off into gluconeogenesis, while beta-oxidation floods the liver with acetyl-CoA. Supply exceeds the capacity to burn it. The liver condenses the excess into ketone bodies: acetoacetate, β-hydroxybutyrate, and acetone.

This is not a pathological accident — it is a strategic conversion. Ketones are water-soluble, travel freely in blood, and — crucially — cross the blood–brain barrier, which fatty acids essentially cannot. The brain, which cannot oxidize fatty acids and normally consumes about 120 g of glucose a day, adapts over three to four days and by three weeks derives 60–70% of its energy from ketones, cutting its glucose requirement to roughly 40 g/day.

That adaptation is why humans survive prolonged starvation. Meeting 120 g of glucose a day entirely by gluconeogenesis from amino acids would consume roughly 200 g of muscle protein daily, and death would follow in about three weeks. Ketogenesis is what buys the extra two months.

Normal blood ketones are below 0.5 mmol/L; nutritional ketosis runs 0.5–3 mmol/L; diabetic ketoacidosis runs 10–25 mmol/L. The difference is not the pathway but the absence of the brake: insulin normally restrains lipolysis, and without any insulin at all the pathway has no upper limit.

Lipogenesis and lipolysis

Lipogenesis converts surplus acetyl-CoA — from carbohydrate as readily as from fat — into fatty acids, via cytosolic acetyl-CoA carboxylase (which makes malonyl-CoA) and fatty acid synthase. It occurs mainly in liver and adipose tissue and is stimulated by insulin.

Lipolysis hydrolyzes stored triglyceride to glycerol and three free fatty acids, by adipose triglyceride lipase and hormone-sensitive lipase. It is activated by glucagon, epinephrine, cortisol, and growth hormone, and inhibited powerfully by insulin — a detail that becomes the whole story in §24.7 and in the Case File.

And here is the asymmetry that governs human metabolism: carbohydrate can become fat, but fat cannot become carbohydrate. The reason is one irreversible reaction. Pyruvate dehydrogenase converts pyruvate to acetyl-CoA and releases a carbon as CO₂; there is no enzyme that runs it backwards. Once carbon is in acetyl-CoA, its only fates are oxidation to CO₂, storage as fat, or conversion to ketones. The two carbons that enter the citric acid cycle as acetyl-CoA are matched by two that leave as CO₂, so no net carbon is available to build glucose.

The only exceptions are marginal: the glycerol backbone of a triglyceride (about 5% of its mass) is glucogenic, and odd-chain fatty acids yield one propionyl-CoA. Fat, essentially, is a one-way store. This is why a person with no carbohydrate intake must make glucose from protein, and why "the body burns fat for the brain" is only true through the intermediary of ketones.

The lipoproteins

Lipids are insoluble in plasma, so they travel wrapped in a shell of phospholipid, free cholesterol, and apolipoproteins, which serve as address labels. Four classes matter, and they differ in density because they differ in the ratio of (light) triglyceride to (heavy) protein.

  THE FOUR LIPOPROTEINS — CARGO, ROUTE, AND ADDRESS LABEL
  ══════════════════════════════════════════════════════════════════════

  ┌─ CHYLOMICRON ── largest (75-1200 nm), least dense ──────────────────┐
  │ MADE BY:  intestinal enterocyte      LABEL: apoB-48                 │
  │ CARGO:    DIETARY triglyceride       ~90% TAG                       │
  │ ROUTE:    lacteal → thoracic duct → subclavian vein → BYPASSES the  │
  │           liver on the way out → capillaries of MUSCLE and ADIPOSE  │
  │           → lipoprotein lipase (LPL) strips TAG → remnant → LIVER   │
  └─────────────────────────────────────────────────────────────────────┘
                    "dietary fat, delivered outward"
  ┌─ VLDL ── very low density ──────────────────────────────────────────┐
  │ MADE BY:  LIVER                      LABEL: apoB-100                │
  │ CARGO:    ENDOGENOUS triglyceride the liver made or received        │
  │ ROUTE:    liver → blood → LPL in muscle and adipose strips TAG      │
  │           → becomes IDL → becomes LDL as more TAG is removed        │
  └─────────────────────────────────────────────────────────────────────┘
                    "the liver's own fat, delivered outward"
  ┌─ LDL ── low density ────────────────────────────────────────────────┐
  │ MADE FROM: VLDL after TAG removal    LABEL: apoB-100                │
  │ CARGO:    ~50% CHOLESTEROL — the delivery vehicle for cholesterol   │
  │ ROUTE:    blood → any cell with an LDL RECEPTOR → clathrin-coated   │
  │           pit → endosome → cholesterol released                     │
  │ WHY "BAD": when LDL exceeds what receptors clear, it lodges in the  │
  │           arterial intima, is OXIDIZED, and is taken up by          │
  │           macrophage SCAVENGER receptors — which are NOT            │
  │           down-regulated by cholesterol. Macrophage → FOAM CELL     │
  │           → fatty streak → ATHEROSCLEROTIC PLAQUE (Ch. 19)          │
  └─────────────────────────────────────────────────────────────────────┘
  ┌─ HDL ── high density, smallest, most protein ───────────────────────┐
  │ MADE BY:  liver and intestine        LABEL: apoA-I                  │
  │ CARGO:    starts nearly empty; PICKS UP cholesterol                 │
  │ ROUTE:    tissues (incl. FOAM CELLS in plaque) → ABCA1/ABCG1        │
  │           efflux → esterified by LCAT → carried to LIVER via SR-B1  │
  │           → excreted in BILE.  "REVERSE cholesterol transport"      │
  │ WHY "GOOD": it is the ONLY route by which cholesterol leaves the    │
  │           body. Also antioxidant and anti-inflammatory.             │
  └─────────────────────────────────────────────────────────────────────┘

   DIRECTION IS THE WHOLE STORY:
     chylomicron, VLDL, LDL  ═══► OUTWARD  (liver/gut → tissues)
     HDL                     ◄═══ INWARD   (tissues → liver → bile)

   AMARA: TAG 244 (high VLDL) · HDL 38 (low) — and these two are LINKED:
   CETP swaps TAG from VLDL into HDL; TAG-rich HDL is cleared faster.
   High triglycerides CAUSE low HDL. One lesion, two numbers.

Figure 24.2 — The four lipoproteins: what each carries, where it goes, and why LDL and HDL have opposite reputations.

Described: Four boxes describe the lipoprotein classes in order of decreasing size and increasing density. Chylomicrons, seventy-five to twelve hundred nanometres and least dense, are made by intestinal enterocytes, labelled with apolipoprotein B-48, carry about ninety percent dietary triglyceride, and travel by lacteal and thoracic duct into the subclavian vein, bypassing the liver on the way out, to capillaries of muscle and adipose tissue where lipoprotein lipase strips the triglyceride; the remnant returns to the liver. Very low density lipoprotein is made by the liver, labelled apolipoprotein B-100, carries endogenous triglyceride outward to the same lipoprotein lipase, and becomes intermediate density and then low density lipoprotein as triglyceride is removed. Low density lipoprotein carries about fifty percent cholesterol and is taken up by any cell bearing an LDL receptor through clathrin-coated pits; it is called bad because when its concentration exceeds receptor clearance it lodges in the arterial intima, becomes oxidized, and is ingested by macrophage scavenger receptors that, unlike LDL receptors, are not down-regulated by cholesterol, converting macrophages into foam cells and building atherosclerotic plaque. High density lipoprotein, smallest and most protein-rich, is made by liver and intestine, labelled apolipoprotein A-I, begins nearly empty, and collects cholesterol from tissues including foam cells through the ABCA1 and ABCG1 transporters; the cholesterol is esterified by LCAT and delivered to the liver through the SR-B1 receptor for excretion in bile. This reverse cholesterol transport is the only route by which cholesterol leaves the body, which is why HDL is called good. Direction is the organizing principle: chylomicrons, VLDL, and LDL travel outward from liver and gut to tissues, while HDL travels inward from tissues to liver to bile. A closing note applies this to the case: Amara's triglycerides of 244 reflect high VLDL and her HDL of 38 is low, and the two are causally linked because cholesteryl ester transfer protein swaps triglyceride from VLDL into HDL, and triglyceride-rich HDL is cleared from the circulation faster — so high triglycerides cause low HDL, and one lesion produces two abnormal numbers.

Clinical Connection · Statins and the Mevalonate Pathway — Why Blocking Synthesis Lowers LDL

Atorvastatin, which Amara takes at 80 mg daily, inhibits HMG-CoA reductase, the rate-limiting enzyme of the mevalonate pathway by which cells synthesize cholesterol from acetyl-CoA.

The obvious inference — "less cholesterol made, so less cholesterol in blood" — is not the main mechanism, and the real one is more interesting. Roughly 70–80% of the body's cholesterol is endogenously synthesized, mostly in the liver, and the liver responds to a fall in its own intracellular cholesterol by activating the transcription factor SREBP-2. SREBP-2 up-regulates the LDL receptor. More LDL receptors on the hepatocyte surface means more LDL particles pulled out of the plasma and degraded. The plasma LDL falls chiefly because the liver starts clearing it faster, not because less is made.

Two consequences follow from that mechanism and are hard to derive any other way. First, patients with homozygous familial hypercholesterolemia, who have essentially no functional LDL receptors, respond poorly to statins — there is no receptor to up-regulate. Second, the mevalonate pathway makes more than cholesterol: it also makes coenzyme Q10, dolichol, and the isoprenoid groups used to prenylate small signalling GTPases. Blocking it upstream reduces all of them, which is the leading hypothesis for statin-associated muscle symptoms.

Histology · White Fat, Brown Fat, and the Hepatocyte

White adipocyte. A single enormous unilocular lipid droplet fills the cell, pushing the nucleus flat against the periphery and leaving a cytoplasmic rim so thin it can be hard to see — the classic "signet ring." Mitochondria are few. In routine processing the lipid dissolves out, so the tissue appears as a delicate honeycomb of empty spaces. Everything about the morphology says storage: maximum volume, minimum machinery.

Brown adipocyte. Many small multilocular droplets, a round central nucleus, and cytoplasm crowded with mitochondria so densely that their cytochromes give the tissue its brown colour. The tissue is richly vascularized and heavily innervated by sympathetic fibres. Everything about this morphology says combustion: many droplet surfaces for lipase to work on, enormous oxidative capacity, a blood supply to carry heat away, and a direct nerve line to switch it on.

Hepatocyte. Large, polyhedral, frequently binucleate and polyploid. Abundant smooth ER (drug and steroid metabolism, and it visibly proliferates under enzyme induction), abundant rough ER and Golgi (albumin and clotting factor export), a thousand or more mitochondria per cell, numerous peroxisomes (very-long-chain fatty acid oxidation, alcohol), and glycogen rosettes plus lipid droplets that dissolve during processing and leave the cytoplasm looking patchy. You can read a hepatocyte's recent metabolic history off its organelles.

In hepatic steatosis the pattern shifts toward large unilocular droplets that displace the nucleus — the hepatocyte starts to look like an adipocyte, which is exactly what "fatty liver" means histologically.

Clinical Connection · Alcohol, the NADH Problem, and Fatty Liver

Ethanol is oxidized by alcohol dehydrogenase to acetaldehyde and then by aldehyde dehydrogenase to acetate, and both steps reduce NAD⁺ to NADH. A moderate drinking session therefore floods the hepatocyte cytosol with NADH and drives the NADH/NAD⁺ ratio sharply upward. Almost every feature of alcohol's metabolic effect follows from that one ratio.

  • Gluconeogenesis is inhibited. It requires NAD⁺ at several steps, and the high NADH pushes pyruvate toward lactate and oxaloacetate toward malate — removing both key gluconeogenic intermediates. Hence fasting hypoglycemia in a drinker who has not eaten, which can be severe and is a real cause of death.
  • Lactate accumulates, producing a mild lactic acidosis, and because lactate and urate compete for renal excretion, hyperuricemia — hence the classic association with gout.
  • Beta-oxidation is inhibited (it too needs NAD⁺) while triglyceride synthesis is promoted, because the excess NADH drives dihydroxyacetone phosphate toward glycerol-3-phosphate, the backbone onto which fatty acids are esterified. Fat accumulates in the hepatocyte: alcoholic fatty liver, reversible at this stage.
  • Acetaldehyde itself forms protein adducts, generates oxidative stress, and activates hepatic stellate cells — the step from reversible steatosis to fibrosis and cirrhosis.

Chronic intake additionally induces CYP2E1, a second oxidizing system that generates reactive oxygen species and accelerates the metabolism of other drugs — including, dangerously, the conversion of acetaminophen to its toxic metabolite.


24.6 Protein Metabolism

Proteins are continuously synthesized and degraded; an adult turns over roughly 300 g of protein a day while eating perhaps 70 g. Most amino acids are recycled. When one is to be used as fuel, its nitrogen must be dealt with first, because nitrogen cannot be burned.

Transamination. An amino group is transferred from an amino acid to α-ketoglutarate, producing glutamate and the original amino acid's carbon skeleton as a keto acid. The enzymes are aminotransferases — ALT and AST, both requiring pyridoxal phosphate from vitamin B₆, and both familiar from liver function tests: they appear in blood when hepatocytes are damaged and release their contents.

Note what transamination does and does not do. It does not remove nitrogen from the body; it funnels nitrogen from twenty different amino acids onto one carrier molecule, glutamate. Twenty problems become one.

Oxidative deamination. In liver mitochondria, glutamate dehydrogenase strips the amino group off glutamate as free ammonia (NH₄⁺), regenerating α-ketoglutarate to collect more.

The urea cycle. Ammonia is extremely toxic — it depletes α-ketoglutarate, interferes with glutamate neurotransmission, and causes cerebral edema. The liver therefore converts it, in five enzymatic steps split between mitochondrion and cytosol, into urea: a small, neutral, water-soluble, non-toxic molecule that the kidney excretes. Each urea molecule disposes of two nitrogens — one from ammonia, one from aspartate — and costs about 4 ATP equivalents. A typical adult excretes about 30 g of urea daily, and its blood concentration is measured as BUN (7–20 mg/dL).

Two clinical inferences: when the liver fails, ammonia rises and produces hepatic encephalopathy; and when the kidney fails, urea rises — which is why the BUN is a measure of renal function even though it is manufactured by the liver.

The carbon skeletons. Once stripped of nitrogen, an amino acid's carbon skeleton enters metabolism at one of seven points. Glucogenic amino acids yield pyruvate or a citric acid cycle intermediate and can become glucose. Ketogenic amino acids yield acetyl-CoA or acetoacetate and cannot. Only leucine and lysine are purely ketogenic; five are both; the rest are glucogenic.

Nitrogen balance compares intake with excretion. Positive balance — intake exceeding excretion — means net protein is being built: growth, pregnancy, recovery, resistance training. Negative balance means net breakdown: starvation, infection, burns, trauma, immobilization, and glucocorticoid excess.

Why protein is the fuel of last resort

Three reasons, all structural:

  1. There is no storage protein. Every gram of protein in your body is doing a job — it is a muscle filament, an enzyme, an antibody, a transporter. Burning protein means dismantling working machinery. Fat and glycogen are inventory; protein is equipment.
  2. The nitrogen is expensive. Disposing of it costs 4 ATP per urea molecule and obligates water loss in urine to excrete it.
  3. The cost is functional and rapid. Losing 30–40% of body protein is generally fatal, and long before that, respiratory muscle weakness, immune failure, and impaired wound healing appear. In starvation the body works hard to avoid this — which is precisely what ketogenesis is for.
  THE METABOLIC MAP — THREE FUELS, ONE INTERSECTION
  ══════════════════════════════════════════════════════════════════════

  CARBOHYDRATE          PROTEIN                    LIPID
  ────────────          ───────                    ─────
   glycogen             body protein               triglyceride
      ▲│                    ▲│                        ▲│
      │▼ glycogenolysis     │▼ proteolysis            │▼ lipolysis
   GLUCOSE              AMINO ACIDS              GLYCEROL + FATTY ACIDS
      │                     │                        │         │
      │ glycolysis          │ TRANSAMINATION         │         │ BETA-
      │ (cytosol)           │ + deamination          │         │ OXIDATION
      │ 2 ATP, 2 NADH       │      │                 │         │ (matrix)
      ▼                     │      ▼                 │         ▼
  ══ PYRUVATE ══◄───────────┤   NH4+ ──► UREA        │    ┌─────────┐
      │        ◄────────────┘   (urea cycle,         │    │ 1 FADH2 │
      │  ▲                       liver, 4 ATP)       │    │ 1 NADH  │
      │  │ gluconeogenesis                           │    │ per cut │
      │  │ (liver, kidney)                           └──► └─────────┘
      │  │ from LACTATE, GLYCEROL,                         │
      │  │ GLUCOGENIC amino acids                          │
      ▼  │                                                 ▼
   ╔══════════════════════════════════════════════════════════════════╗
   ║                        A C E T Y L - C o A                       ║
   ║   ◄── the one-way door.  Pyruvate → acetyl-CoA is IRREVERSIBLE   ║
   ║       ∴ FAT CANNOT BECOME GLUCOSE.  Glucose CAN become fat.      ║
   ╚══════════════════════════════════════════════════════════════════╝
       │                    │                          │
       │ + oxaloacetate     │ lipogenesis              │ (if OAA is
       ▼                    ▼                          ▼  scarce)
   ┌────────────────┐   FATTY ACIDS              KETONE BODIES
   │  CITRIC ACID   │   → triglyceride           acetoacetate,
   │     CYCLE      │                            b-hydroxybutyrate
   │  3 NADH        │                            → CROSS the blood-
   │  1 FADH2       │                              brain barrier
   │  1 ATP         │                            → brain fuel in
   │  2 CO2         │                              starvation
   └───────┬────────┘
           │  all the NADH and FADH2 from EVERY pathway above
           ▼
   ┌──────────────────────────────────────────────────────────────────┐
   │  ELECTRON TRANSPORT CHAIN + CHEMIOSMOSIS  (inner mito. membrane) │
   │  NADH → 2.5 ATP · FADH2 → 1.5 ATP · O2 is the FINAL acceptor →   │
   │  H2O.  ~90% of all ATP you make.                                 │
   └──────────────────────────────────────────────────────────────────┘

Figure 24.3 — The metabolic map: carbohydrate, protein, and lipid pathways converging on acetyl-CoA and the citric acid cycle.

Described: Three vertical fuel pathways converge on a central box. On the left, carbohydrate: glycogen interconverts with glucose by glycogenesis and glycogenolysis, and glucose passes through cytosolic glycolysis, yielding two ATP and two NADH, to pyruvate. In the centre, protein: body protein yields amino acids, which undergo transamination and oxidative deamination; the nitrogen becomes ammonium and is converted to urea by the hepatic urea cycle at a cost of four ATP, while the carbon skeletons enter as pyruvate or as citric acid cycle intermediates. On the right, lipid: triglyceride is hydrolyzed by lipolysis to glycerol and fatty acids, and the fatty acids undergo beta-oxidation in the mitochondrial matrix, each two-carbon cut yielding one FADH2, one NADH, and one acetyl-CoA. Pyruvate can be regenerated from lactate, glycerol, and glucogenic amino acids by gluconeogenesis in liver and kidney. All three pathways converge on acetyl-CoA, labelled the one-way door: because the conversion of pyruvate to acetyl-CoA is irreversible, fat cannot become glucose although glucose can become fat. From acetyl-CoA, three fates branch: condensation with oxaloacetate into the citric acid cycle, which yields three NADH, one FADH2, one ATP, and two carbon dioxide per turn; lipogenesis to fatty acids and triglyceride; and, when oxaloacetate is scarce, ketone body formation producing acetoacetate and beta-hydroxybutyrate, which cross the blood-brain barrier and fuel the brain in starvation. All the NADH and FADH2 generated by every pathway feed the electron transport chain and chemiosmosis at the inner mitochondrial membrane, where each NADH yields about two and a half ATP and each FADH2 about one and a half, oxygen serves as the final electron acceptor and becomes water, and roughly ninety percent of all ATP is produced.

Clinical Connection · Phenylketonuria — One Enzyme, Two Consequences

Phenylalanine hydroxylase converts the essential amino acid phenylalanine into tyrosine. Roughly 1 in 10,000–15,000 newborns inherits two defective copies, and the consequences follow in two directions from a single blocked arrow.

Upstream, phenylalanine accumulates to 20 times normal. Excess is shunted down a minor pathway to phenylketones, which appear in urine (hence the name). High phenylalanine is directly neurotoxic and also competes with tyrosine and tryptophan for the shared large neutral amino acid transporter at the blood–brain barrier, starving the brain of the precursors for dopamine, norepinephrine, and serotonin. Untreated, the result is severe, permanent intellectual disability.

Downstream, tyrosine becomes essential — a nonessential amino acid converted into an essential one by a missing enzyme, which is the cleanest possible illustration of what "essential" actually means. Tyrosine is also the precursor of melanin, which is why untreated children are characteristically fair-haired and light-skinned.

Treatment is dietary phenylalanine restriction begun within days of birth, which is why newborn screening exists and why it is one of the highest-return public health programmes ever implemented. Two practical points fall out of the biochemistry: phenylalanine cannot be eliminated entirely, because it is essential and required for protein synthesis, so the diet is a titration rather than an exclusion; and aspartame is a dipeptide of aspartate and phenylalanine, which is why every product containing it carries a warning aimed at perhaps one person in ten thousand.


24.7 The Absorptive and Postabsorptive States

Everything in the four previous sections is a capability. What determines which capabilities run at any moment is a hormonal switch with two positions.

The absorptive (fed) state occupies roughly the four hours after a meal, while nutrients are entering the blood from the gut. The dominant hormone is insulin, and the instruction is one word: store.

The postabsorptive (fasting) state occupies the rest of the time, including all of the night. The dominant hormones are glucagon, and — with escalating stress or duration — epinephrine, cortisol, and growth hormone. The instruction is: mobilize, and above all, defend blood glucose.

That last phrase is the key to the whole section. The regulated variable in the postabsorptive state is plasma glucose, held at 70–100 mg/dL, and the reason is the brain. The brain consumes about 120 g of glucose a day, cannot store any, cannot oxidize fatty acids, and takes up glucose by insulin-independent GLUT1 and GLUT3 transporters — meaning it takes what it needs regardless of hormonal signalling. Every other tissue's fuel arrangement in the fasting state is designed around leaving that glucose alone.

  THE TWO METABOLIC STATES — SAME ORGANS, OPPOSITE PROGRAMS
  ══════════════════════════════════════════════════════════════════════

  ABSORPTIVE (FED) STATE                POSTABSORPTIVE (FASTING) STATE
  ═══ INSULIN dominant ═══              ═══ GLUCAGON / EPI / CORTISOL ═══
  "STORE"                               "MOBILIZE — but spare glucose"

  GUT ──glucose,AA──► PORTAL VEIN       GUT: empty
       ──chylomicrons──► LYMPH
            │                                  ┌──────────────┐
            ▼                                  │    BRAIN     │ needs
  ┌───────────────────┐                        │  ~120 g/day  │ glucose
  │      LIVER        │                        │  GLUT1/GLUT3 │ ALWAYS
  │ glucose IN (GLUT2)│                        │  (insulin-   │
  │ ► GLYCOGENESIS    │                        │   INDEPENDENT)│
  │ ► LIPOGENESIS     │                        └──────▲───────┘
  │ ► protein synth.  │                               │ glucose
  │ ► VLDL export     │                        ┌──────┴────────────┐
  │ gluconeogenesis   │                        │      LIVER        │
  │        OFF        │                        │ ► GLYCOGENOLYSIS  │
  └─────────┬─────────┘                        │   (~100 g, gone   │
            │                                  │    in 12-24 h)    │
            ▼ glucose to periphery             │ ► GLUCONEOGENESIS │
  ┌───────────────────┐                        │   from lactate,   │
  │  SKELETAL MUSCLE  │                        │   glycerol, ALANINE│
  │ GLUT4 → membrane  │                        │ ► KETOGENESIS     │
  │ ► glycogen synth. │                        └───▲───────────▲───┘
  │   (~400 g store)  │                            │           │
  │ ► AA uptake,      │                     alanine│           │glycerol
  │   protein synth.  │                     lactate│           │+ FFA
  └───────────────────┘                     ┌──────┴─────┐  ┌──┴────────┐
  ┌───────────────────┐                     │   MUSCLE   │  │  ADIPOSE  │
  │     ADIPOSE       │                     │ burns FFA  │  │ LIPOLYSIS │
  │ GLUT4 → membrane  │                     │ NOT glucose│  │ ON (HSL   │
  │ ► LPL ACTIVATED   │                     │ exports    │  │ un-       │
  │   (grabs TAG from │                     │ alanine +  │  │ inhibited)│
  │   chylo + VLDL)   │                     │ lactate    │  │ → FFA +   │
  │ ► TAG storage     │                     │ proteolysis│  │   glycerol│
  │ ► HSL INHIBITED   │                     │ (LAST      │  │           │
  │   lipolysis OFF   │                     │  resort)   │  │           │
  └───────────────────┘                     └────────────┘  └───────────┘

  ══════════════════════════════════════════════════════════════════════
  INSULIN RESISTANCE (Amara): the switch STICKS IN THE FASTING POSITION
  ══════════════════════════════════════════════════════════════════════
     LIVER   gluconeogenesis NOT switched off  → fasting glucose 212
     ADIPOSE lipolysis NOT switched off        → FFA flux to liver ↑
                                               → VLDL export ↑ → TAG 244
                                               → CETP → HDL 38
     MUSCLE  GLUT4 does NOT reach the membrane → post-meal glucose ↑↑
     BETA CELL compensates → fasting insulin 28 uU/mL (high!)
     RESULT: the POSTABSORPTIVE program running DURING the ABSORPTIVE
             state. Both programs at once. Hyperglycemia + hyperinsulinemia
             + hypertriglyceridemia are ONE lesion, not three.

Figure 24.4 — The absorptive and postabsorptive states as contrasting organ-by-organ substrate flows, and what insulin resistance does to the switch.

Described: Two contrasting organ-flow diagrams. In the absorptive or fed state, insulin dominates and the instruction is to store. Glucose and amino acids enter the portal vein from the gut while chylomicrons enter the lymph. The liver takes up glucose through GLUT2 and runs glycogenesis, lipogenesis, protein synthesis, and VLDL export, with gluconeogenesis switched off. Skeletal muscle translocates GLUT4 to its membrane, takes up glucose for glycogen synthesis toward a store of about four hundred grams, and takes up amino acids for protein synthesis. Adipose tissue translocates GLUT4, activates lipoprotein lipase to capture triglyceride from chylomicrons and VLDL, stores triglyceride, and inhibits hormone-sensitive lipase so lipolysis is off. In the postabsorptive or fasting state, glucagon, epinephrine, and cortisol dominate and the instruction is to mobilize while sparing glucose for the brain, which requires about one hundred twenty grams a day and takes it up through insulin-independent GLUT1 and GLUT3 transporters. The liver runs glycogenolysis, exhausting its roughly one hundred gram store within twelve to twenty-four hours, then gluconeogenesis from lactate, glycerol, and alanine, and ketogenesis. Muscle burns free fatty acids rather than glucose and exports alanine and lactate to the liver, resorting to proteolysis only last. Adipose tissue runs lipolysis with hormone-sensitive lipase uninhibited, exporting free fatty acids and glycerol. A final panel applies this to insulin resistance, in which the switch sticks in the fasting position: the liver fails to switch off gluconeogenesis, giving a fasting glucose of 212; adipose fails to switch off lipolysis, raising free fatty acid delivery to the liver, which raises VLDL export and triglycerides to 244 and, through cholesteryl ester transfer protein, lowers HDL to 38; muscle GLUT4 fails to reach the membrane, raising post-meal glucose; and the beta cell compensates, giving a fasting insulin of 28 microunits per millilitre. The postabsorptive program is running during the absorptive state, so hyperglycemia, hyperinsulinemia, and hypertriglyceridemia are one lesion rather than three.

The hormonal control map

Hormone Source Trigger Net effect on blood glucose Principal actions
Insulin Pancreatic beta cells Rising glucose; incretins (GIP, GLP-1); amino acids ↓ Lowers GLUT4 to membrane in muscle and fat; glycogenesis; lipogenesis; protein synthesis; inhibits lipolysis, gluconeogenesis, ketogenesis
Glucagon Pancreatic alpha cells Falling glucose; amino acids ↑ Raises Glycogenolysis, gluconeogenesis, ketogenesis — liver only
Epinephrine Adrenal medulla Stress, exercise, hypoglycemia ↑ Raises Glycogenolysis (liver and muscle), lipolysis, inhibits insulin release
Cortisol Adrenal cortex Prolonged stress; circadian peak at waking ↑ Raises Gluconeogenesis, proteolysis, lipolysis; antagonizes insulin at the receptor
Growth hormone Anterior pituitary Fasting, sleep, exercise ↑ Raises Lipolysis, glucose sparing, protein anabolism

One asymmetry is worth pausing on. One hormone lowers blood glucose; four raise it. That imbalance is not sloppiness — it is a statement of relative risk. Hypoglycemia kills within minutes by starving the brain; hyperglycemia kills over years. Evolution built redundancy where failure is fast.

Thread 2 · Homeostasis Is the Master Concept

Amara's fasting glucose of 212 mg/dL is not a failure of glucose production. Her body makes plenty. It is a failure of switching.

Map it onto the control loop from Chapter 1. The variable is plasma glucose. The receptor is the pancreatic beta cell, and it works — it senses hyperglycemia correctly and secretes insulin, which is why her fasting insulin is elevated at 28 µU/mL rather than low. The control centre is the beta cell's secretory apparatus, and it also works. What has failed is the effector limb: the target tissues no longer respond to the signal. Insulin arrives at the liver and the liver does not switch off gluconeogenesis; it arrives at adipose tissue and lipolysis does not stop; it arrives at muscle and GLUT4 stays in its vesicles.

This is why type 2 diabetes is so unlike type 1, in which the receptor and control centre are destroyed and there is no signal at all. It is also why the compensating hyperinsulinemia is itself part of the disease: the beta cell responds to a failing effector by shouting louder, and after years of shouting, it fails too. A homeostatic loop that cannot correct its variable destroys its own sensor.

The postabsorptive sequence, hour by hour

Time since eating Dominant glucose source Notes
0–4 h Absorbed dietary glucose Absorptive state; insulin high
4–12 h Hepatic glycogenolysis ~100 g store; this is the normal overnight fast
12–24 h Glycogenolysis fading, gluconeogenesis rising Both contribute; glycogen essentially gone by ~24 h
24 h – 3 days Gluconeogenesis, mainly from amino acids Muscle protein loss is at its highest, ~75 g/day
3 days – 3 weeks Gluconeogenesis plus ketone adaptation Brain shifts to ketones; protein loss falls to ~20 g/day
Beyond ~3 weeks Fat stores nearly exhausted; obligatory proteolysis resumes Death follows loss of ~30–40% of body protein

Clinical Connection · Diabetic Ketoacidosis versus Hyperosmolar Hyperglycemic State

Both are extreme hyperglycemic emergencies. The difference between them is how much insulin is left, and it turns on one physiological fact: adipose tissue is the most insulin-sensitive tissue in the body. It takes only a very small amount of insulin to suppress lipolysis — far less than is needed to suppress hepatic gluconeogenesis or to move GLUT4 in muscle.

DKA HHS
Typical setting Type 1 diabetes; absolute insulin deficiency Type 2 diabetes; relative deficiency with residual insulin
Glucose 350–800 mg/dL Often > 600, sometimes > 1000
Ketones High — lipolysis unrestrained Minimal — residual insulin still suppresses lipolysis
pH / bicarbonate pH < 7.30, HCO₃⁻ < 18, high anion gap Near normal
Osmolality Mildly raised > 320 mOsm/kg — profound dehydration
Signature findings Kussmaul respirations, fruity breath (acetone), abdominal pain Marked obtundation, focal neurological signs
Onset Hours to a day Days to weeks
Mortality ~1–5% ~10–20%

The reasoning to take away: ketosis is a marker of complete insulin absence, which is why Amara — with a fasting insulin of 28 µU/mL — is at essentially no risk of DKA but at real risk of HHS if an infection or a missed dose lets her glucose climb unchecked. The higher mortality of HHS is partly because its slower onset produces no dramatic early symptom to bring the patient in.

Clinical Connection · Refeeding Syndrome — When Treatment Is the Danger

A severely malnourished patient — after prolonged starvation, anorexia nervosa, alcohol use disorder, or major illness — has been running the postabsorptive program for weeks. Total body stores of phosphate, potassium, magnesium, and thiamine are depleted, though serum levels may look normal because the ions have shifted out of shrunken cells.

Feed that patient carbohydrate and insulin surges for the first time in weeks. Everything the absorptive program does then happens at once:

  • Glucose is driven into cells, and phosphate follows to phosphorylate it and to make ATP. Serum phosphate can crash below 1.0 mg/dL, causing rhabdomyolysis, hemolysis, respiratory muscle failure, and cardiac arrhythmia.
  • Potassium and magnesium shift intracellularly with the same anabolic surge, causing arrhythmias and seizures.
  • Thiamine, already depleted, is consumed rapidly as pyruvate dehydrogenase is asked to process a carbohydrate load — precipitating Wernicke encephalopathy.
  • Insulin's renal sodium-retaining action, plus the new osmotic load, produces fluid overload in a heart with reduced mass.

The management follows directly from the mechanism: identify risk before feeding, give thiamine first, start at 10–20 kcal/kg/day rather than a normal ration, replace phosphate, potassium, and magnesium proactively, and monitor daily. The lesson generalizes beyond nutrition: a body that has adapted to a deficit is not in a neutral state, and reversing the deficit rapidly can be more dangerous than the deficit itself.

Check Your Understanding 24.7

  1. Why does a person with type 1 diabetes lose weight despite eating normally and having a very high blood glucose?
  2. Why is fasting insulin high in early type 2 diabetes but low in type 1?
  3. During a 36-hour fast, blood glucose falls from 90 to 70 mg/dL and stops falling. What is holding it there, and what is the fuel cost?
Show answers
  1. Because without insulin the cells cannot access the glucose, so they are metabolically starving in the presence of abundant fuel. The body reads this as extreme fasting and runs the postabsorptive program at full power: unrestrained lipolysis, proteolysis, hepatic gluconeogenesis, and ketogenesis. Meanwhile, glucose above the renal threshold of about 180 mg/dL spills into the urine and drags water with it osmotically, so calories and fluid are lost directly. Weight falls from fat loss, muscle loss, and dehydration simultaneously.
  2. In type 2, the beta cell is intact and is compensating for target tissues that no longer respond, so it secretes more insulin than normal — hyperinsulinemia is a marker of resistance, not of adequacy. In type 1, the beta cells have been destroyed by autoimmune attack, so there is little or no insulin to measure. Measuring insulin (or C-peptide) alongside glucose therefore distinguishes a signalling failure from a signal-production failure.
  3. Almost entirely hepatic gluconeogenesis, since liver glycogen is largely exhausted by 24 hours. Its substrates are glycerol released by lipolysis, lactate returning by the Cori cycle, and glucogenic amino acids — chiefly alanine — released by muscle proteolysis. The cost is roughly 75 g of muscle protein per day at this stage, plus about 6 ATP for every glucose synthesized, an energy bill paid by oxidizing fatty acids. Ketone adaptation has not yet taken over at 36 hours, which is why protein loss is at its peak in the first days of a fast rather than later.

24.8 Energy Balance and Body Composition

Basal metabolic rate

BMR is the energy required to keep a resting, awake, fasted, thermoneutral person alive — the cost of ion pumping, protein turnover, breathing, and circulation. It is measured under strict conditions; the more practical resting metabolic rate (RMR) is measured under relaxed ones and runs a few percent higher. A typical adult woman's BMR is about 1,300–1,500 kcal/day and a man's about 1,600–1,800.

What actually determines it:

Factor Effect Why
Fat-free mass The dominant factor — explains 60–80% of the variance Muscle and organs are metabolically active; fat is not. Liver, brain, heart, and kidney together are ~6% of body mass and ~60% of BMR
Body size / surface area Larger → higher absolute BMR More tissue and more surface for heat loss
Sex Males higher for a given body mass Greater fat-free mass, not a separate mechanism
Age Declines with age Chiefly through loss of fat-free mass; recent large studies show BMR adjusted for fat-free mass is remarkably stable from 20 to 60, then falls ~0.7%/year
Thyroid hormone The single most powerful hormonal regulator Increases Na⁺/K⁺ ATPase density and mitochondrial activity; hyperthyroid BMR can be +100%, hypothyroid −30%
Sympathetic activity Raises Epinephrine and norepinephrine increase metabolic rate
Fever +13% per °C (+7% per °F) Enzyme kinetics
Undernutrition Lowers, by more than mass loss predicts Adaptive thermogenesis — a defended set point

Total energy expenditure

TEE has four components:

  • BMR — 60–75% of the total. The largest and least changeable.
  • Thermic effect of food (TEF) — about 10%. The cost of digesting, absorbing, and storing what you eat. It is not equal across macronutrients: protein costs 20–30% of its own energy content, carbohydrate 5–10%, fat 0–3%. This is a real, if modest, part of why higher-protein diets aid weight management.
  • Physical activity — the most variable component, 15–30% in most people and up to 50% or more in an athlete.
  • NEAT (non-exercise activity thermogenesis) — fidgeting, posture, standing, walking to the printer. It can vary by 2,000 kcal/day between individuals of the same size, and it falls substantially during energy restriction, which is one of the quieter reasons weight loss slows.
  WHERE THE CALORIES GO — AND WHAT A RESPIRATORY QUOTIENT TELLS YOU
  ══════════════════════════════════════════════════════════════════════

  TOTAL ENERGY EXPENDITURE, sedentary adult ~2,000 kcal/day
  ┌──────────────────────────────────────────────────────────────┐
  │████████████████████████████████████│▒▒▒▒▒▒▒│░░░░░░░░░│▓▓▓▓▓▓▓│
  └──────────────────────────────────────────────────────────────┘
   BMR 60-75%                           ACTIVITY  NEAT      TEF
   ~1,300-1,500 kcal                    15-30%    variable  ~10%

   Within BMR itself:  liver 20% · brain 20% · muscle 20% (at REST)
                       heart 10% · kidney 8% · everything else 22%
   Note: brain = 2% of body mass, 20% of resting energy.

  SAME PERSON, TRAINING FOR A MARATHON  ~3,400 kcal/day
  ┌──────────────────────────────────────────────────────────────┐
  │██████████████████████│▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒▒│░░░│▓▓▓▓│
  └──────────────────────────────────────────────────────────────┘
   BMR (barely changed)   ACTIVITY now the largest slice

  ── MEASURING IT ──────────────────────────────────────────────────────
  DIRECT calorimetry    person in a sealed chamber; measure HEAT.
                        Accurate, and almost never used — vast and slow.
  INDIRECT calorimetry  measure O2 consumed and CO2 produced.
                        Since ~all O2 use is oxidative phosphorylation,
                        O2 consumption IS energy expenditure.
                        ~4.7-5.0 kcal per litre of O2 consumed.

  ── RESPIRATORY EXCHANGE RATIO   RER = VCO2 / VO2 ─────────────────────

    0.70 ────────────────────────────────────────  100% FAT
      |    palmitate: C16H32O2 + 23 O2 → 16 CO2 + 16 H2O
      |    16/23 = 0.70   (fat is hydrogen-rich, needs EXTRA O2)
    0.80 ───────────────────────  mixed diet at rest / ~protein
      |
    0.85 ───────────────────────  moderate exercise, ~50% each
      |
    1.00 ────────────────────────────────────────  100% CARBOHYDRATE
      |    glucose: C6H12O6 + 6 O2 → 6 CO2 + 6 H2O    6/6 = 1.00
      |
    >1.00  NOT a fuel reading. Excess CO2 from BICARBONATE buffering
           of lactic acid during hard exercise, or from hyperventilation.

Figure 24.5 — Components of total energy expenditure, how expenditure is measured, and the interpretation of the respiratory exchange ratio.

Described: Two stacked horizontal bars compare energy expenditure. For a sedentary adult totalling about two thousand kilocalories per day, basal metabolic rate accounts for sixty to seventy-five percent, roughly thirteen to fifteen hundred kilocalories; physical activity for fifteen to thirty percent; non-exercise activity thermogenesis for a variable slice; and the thermic effect of food for about ten percent. Within basal metabolic rate, the liver accounts for twenty percent, the brain twenty percent, resting skeletal muscle twenty percent, the heart ten percent, the kidneys eight percent, and everything else twenty-two percent; the brain is only two percent of body mass but twenty percent of resting energy use. In the same person training for a marathon, total expenditure rises to about thirty-four hundred kilocalories with basal rate barely changed, so physical activity becomes the largest slice. Measurement is described two ways: direct calorimetry places the person in a sealed chamber and measures heat, which is accurate but rarely practical; indirect calorimetry measures oxygen consumed and carbon dioxide produced, and because essentially all oxygen use is oxidative phosphorylation, oxygen consumption is itself a measure of energy expenditure at about four point seven to five kilocalories per litre of oxygen. The respiratory exchange ratio, carbon dioxide produced divided by oxygen consumed, reads zero point seven for pure fat oxidation, because palmitate requires twenty-three oxygen molecules to yield sixteen of carbon dioxide; about zero point eight for a mixed diet at rest and for protein; about zero point eight five during moderate exercise with roughly equal fuel contributions; and one point zero for pure carbohydrate, because glucose consumes six oxygen and yields six carbon dioxide. Values above one point zero are not a fuel reading at all but reflect extra carbon dioxide from bicarbonate buffering of lactic acid during hard exercise, or from hyperventilation.

Predict This

Leptin is secreted by adipose tissue in proportion to fat mass and acts on the hypothalamus to suppress appetite. When it was discovered in 1994 it was widely expected to be the cure for obesity. Before reading on: predict the leptin level in a person with obesity, and predict whether giving them more leptin will work.

(Answer: their leptin is high, not low — and the reason giving more does not work tells you what leptin actually evolved to signal.)

The regulation of food intake

Body weight is not a passive arithmetic outcome; it is defended. The machinery sits mainly in the arcuate nucleus of the hypothalamus, which lies next to a leaky region of the blood–brain barrier so that it can sample circulating signals directly. It contains two antagonistic neuron populations:

  • NPY/AgRP neuronsorexigenic: they increase appetite and reduce energy expenditure.
  • POMC/CART neuronsanorexigenic: they suppress appetite and increase expenditure.

The signals that act on them:

Signal Source Timescale Action
Leptin Adipocytes, in proportion to fat mass Long-term (days–weeks) Inhibits NPY/AgRP, stimulates POMC — suppresses appetite
Insulin Beta cells, in proportion to adiposity and meals Medium Similar central action to leptin
Ghrelin Gastric fundus, rising before meals Short (hours) Stimulates NPY/AgRP — the only well-established orexigenic hormone
PYY, GLP-1, CCK Gut, after eating Short Satiety; terminate the meal

Why weight is defended, and defended asymmetrically. Leptin was discovered in 1994 amid expectation that obesity would prove to be leptin deficiency and be curable with leptin. It is not: people with obesity have high leptin and are leptin resistant. The deeper insight is that leptin's evolved role is as a starvation signal, not a satiety signal. A falling leptin level is a powerful alarm that triggers hunger, reduces energy expenditure, suppresses reproduction and thyroid output, and does not relent. A rising leptin level is a weak signal that is easily overridden.

That asymmetry is why weight loss is defended against so much harder than weight gain, and it predicts the clinical observation that after a 10% weight loss, measured energy expenditure sits roughly 10–15% below what body composition predicts — adaptive thermogenesis — while hunger hormones move in the direction that promotes regain, and stay there for years.

Body composition

Method Principle Strength Limitation
BMI (kg/m²) Weight scaled to height² Free, universal, epidemiologically useful Cannot distinguish fat from muscle, or where fat is; misclassifies muscular and older adults
Waist circumference / waist-to-height Proxy for visceral fat Cheap; predicts metabolic risk better than BMI Operator technique matters
Skinfolds Subcutaneous fat thickness at set sites Cheap, portable Assumes a fixed subcutaneous-to-total ratio; poor in obesity
Bioelectrical impedance Lean tissue conducts, fat resists Fast, cheap Highly sensitive to hydration
Hydrostatic weighing / air displacement Density → two-compartment model Accurate Assumes fixed density of lean tissue
DEXA Two X-ray energies, differential attenuation Three compartments (bone, fat, lean); regional detail; ~1–2% precision Cost; small radiation dose
MRI / CT Cross-sectional imaging The only methods that separate visceral from subcutaneous fat Expensive; CT carries dose

The essential limitation of BMI is that it measures neither of the two things that actually predict risk: how much of the mass is fat, and where the fat is. Amara's BMI of 29.3 places her below the obesity threshold, and yet her waist of 96 cm and her metabolic profile identify a substantially higher-risk phenotype than the number suggests. Visceral fat is metabolically distinct — more lipolytically active, drained directly into the portal vein so its free fatty acids reach the liver first, and a source of inflammatory cytokines. Two people with identical BMI and different fat distribution do not have the same disease risk, and no height-and-weight formula can tell them apart.

Imaging · Measuring a Body's Composition Three Ways

DEXA (dual-energy X-ray absorptiometry). Two X-ray beams of different energies are passed through the body; bone, fat, and lean soft tissue attenuate them by different ratios, so the three can be solved for separately, pixel by pixel. It gives whole-body and regional fat, lean mass, and bone mineral content at 1–2% precision for a dose of roughly 0.001–0.01 mSv — less than a day of background radiation. It is the practical clinical reference standard, and the same scan that measures Adwoa's osteoporosis (Chapter 6) measures Amara's body composition.

MRI and CT for visceral versus subcutaneous fat. These are the only widely available methods that distinguish the two. A single axial slice at the L4–L5 level correlates strongly with total visceral fat volume and is the standard research measure. The distinction matters because subcutaneous fat drains into the systemic circulation while visceral fat drains into the portal vein, delivering free fatty acids and inflammatory cytokines directly to the liver — which is the anatomical basis for visceral fat's disproportionate metabolic effect.

Indirect calorimetry. A ventilated canopy hood or mouthpiece measures inspired and expired oxygen and carbon dioxide over 15–30 minutes. From VO₂ and VCO₂, the Weir equation gives resting energy expenditure directly, and the RER gives the fuel mix. This is how an intensive care unit decides how many calories to feed a critically ill patient rather than guessing from a population equation, and it is how the substrate crossover data of §24.10 were generated.

Aging · Why the Numbers Drift from 20 to 90

Basal metabolic rate falls — but not the way it is usually described. Large multi-national studies using doubly labelled water have shown that total energy expenditure, adjusted for fat-free mass, is essentially flat from age 20 to 60, then declines about 0.7% per year. The familiar "your metabolism slows in your thirties" is mostly an artefact: what actually changes before 60 is body composition, not metabolic rate per kilogram of lean tissue.

Sarcopenia is the driver. Muscle mass falls roughly 3–8% per decade after 30 and faster after 60, with preferential loss of type II fibres, fewer satellite cells, reduced mitochondrial function, and anabolic resistance — older muscle needs a larger protein dose to mount the same synthetic response, which is why protein requirements rise with age even as appetite falls.

Sarcopenic obesity is the clinically dangerous combination: fat mass rises while muscle mass falls, often at stable body weight and therefore at an unchanged BMI. The person looks the same on the scale and has lost the tissue that consumes glucose. It is a direct route into insulin resistance and frailty at once, and it is invisible to any measurement that does not separate fat from lean.

Thermoregulation narrows at both ends. Sweat gland output falls, cutaneous vasodilation and vasoconstriction are blunted, thirst perception is reduced, shivering is weaker, brown adipose tissue is largely gone, and the lower basal rate means less heat is produced at rest. Older adults are therefore more vulnerable to both hyperthermia and hypothermia, and their core temperature response to infection is blunted — which is why an older adult with serious sepsis may present with a normal temperature, or a low one.


24.9 Body Temperature Regulation

Only about a third of the energy released by oxidizing fuel is captured as ATP (Figure 24.1). The other two-thirds appears as heat — and that heat is not a loss. It is the entire reason a human can maintain a core temperature of 37 °C in a 20 °C room, and thermoregulation is the management of a by-product that happens to be essential.

What follows is the metabolic view of that management: where the heat comes from, and the four physical routes by which it leaves. Chapter 25 takes the same subject as a system in its own right — the controller, its set point, and what happens at the edges of human thermal tolerance.

Why it must be defended. Enzyme activity is temperature-dependent: reaction rates roughly double for every 10 °C rise, and above about 41 °C proteins begin to denature and membranes to fail. Below about 34 °C, reactions slow enough that consciousness, cardiac conduction, and coagulation are impaired. The usable window is narrow, and the same thermoregulatory machinery defends both edges.

Core and shell. The body is not one temperature. The core — brain, thoracic and abdominal viscera — is held near 37.0 °C with a circadian swing of about 0.5–1.0 °C, lowest around 04:00 and highest in the late afternoon. (Amara's twenty years of night shift have been fighting that rhythm, which is one of the several reasons shift work is metabolically costly.) The shell — skin and subcutaneous tissue — is deliberately allowed to vary by many degrees, and manipulating its temperature by changing its blood flow is the body's principal thermoregulatory tool.

Heat production comes from BMR, muscle activity (voluntary and shivering), the thermic effect of food, thyroid hormone, and sympathetic/epinephrine stimulation. Shivering can raise heat production three- to fivefold.

Heat loss occurs by exactly four physical routes:

Route Mechanism Share at rest, 21 °C Notes
Radiation Infrared emission to cooler surroundings; no contact needed ~60% The dominant route at rest; depends on skin-to-environment temperature difference
Conduction Direct transfer to a touching object ~3% Small in air, enormous in water (~25× air's conductivity)
Convection Heated air carried away and replaced ~15% Wind or a fan multiplies it; the basis of wind chill
Evaporation Vaporization of water; 0.58 kcal per mL ~22% ~600 mL/day insensible loss; the only route that works when ambient temperature exceeds skin temperature

That last row is the one to remember. Once the environment is warmer than the skin, radiation, conduction, and convection all reverse and add heat. Above roughly 35 °C ambient, evaporation is the only cooling mechanism you have — which is why high humidity, by preventing evaporation, turns a survivable temperature into a lethal one, and why anything that blocks sweating is a heat emergency waiting for a hot day (Chapter 1's anticholinergic case).

  THE THERMOREGULATORY LOOP AND THE FOUR ROUTES OF HEAT LOSS
  ══════════════════════════════════════════════════════════════════════

                    ┌───────────────────────────────────┐
                    │  HYPOTHALAMUS — preoptic area     │  SET POINT
                    │  compares CORE temp to SET POINT  │  37.0 C
                    └────────┬─────────────────┬────────┘
              too COLD ◄─────┘                 └─────► too HOT
                    │                                 │
   ┌────────────────▼──────────────┐   ┌──────────────▼────────────────┐
   │ HEAT-PROMOTING RESPONSES      │   │ HEAT-LOSS RESPONSES           │
   │ • cutaneous VASOCONSTRICTION  │   │ • cutaneous VASODILATION      │
   │   (shell insulates core)      │   │   (up to 8 L/min to skin)     │
   │ • SHIVERING (3-5x heat prod.) │   │ • SWEATING (up to 1.5 L/h;    │
   │ • NONSHIVERING THERMOGENESIS  │   │   0.58 kcal per mL evaporated)│
   │   (brown fat, UCP1 — infants) │   │ • behaviour: shade, less      │
   │ • piloerection (vestigial)    │   │   clothing, stillness         │
   │ • behaviour: clothing, curl   │   │                               │
   │   up, seek warmth             │   │                               │
   └───────────────────────────────┘   └───────────────────────────────┘
              ▲                                        │
              │        CORE TEMPERATURE 37.0 C         ▼
              └────────────◄── negative feedback ──────┘
        sensed by: PERIPHERAL thermoreceptors (skin — early warning)
                   CENTRAL thermoreceptors (hypothalamus — the real vote)

  ── THE FOUR PHYSICAL ROUTES OUT ──────────────────────────────────────

      RADIATION  ~60%   ((( infrared ))) → cooler objects, NO contact
      CONVECTION ~15%   ~~~ moving air carries heated layer away ~~~
      CONDUCTION  ~3%   ▓▓ direct contact ▓▓  (x25 in WATER)
      EVAPORATION ~22%  ^^^ 0.58 kcal per mL of sweat EVAPORATED ^^^
                        ▲ only route that works when ambient > skin temp
                        ▲ blocked by HUMIDITY — sweat that drips is wasted

  ── FEVER: the set point MOVES ────────────────────────────────────────
     pyrogens (LPS; IL-1, IL-6, TNF) → PGE2 in preoptic area
       → SET POINT 37 → 39 C
       → body now reads itself as TOO COLD: chills, shivering,
         vasoconstriction — every heat-PROMOTING response, correctly run
       → PLATEAU at the new set point
       → pyrogen cleared or COX blocked (aspirin!) → set point back to 37
       → body now reads itself as TOO HOT: drenching sweat = the CRISIS
     Nothing in the loop is broken. Only the TARGET changed.

Figure 24.6 — The hypothalamic thermoregulatory loop, its two effector arms, the four physical routes of heat loss, and what changes in fever.

Described: A negative feedback loop centred on the preoptic area of the hypothalamus, which compares core temperature against a set point of thirty-seven degrees Celsius using input from peripheral thermoreceptors in the skin, which give early warning, and central thermoreceptors in the hypothalamus itself, which carry the decisive signal. If the body is too cold, heat-promoting responses are activated: cutaneous vasoconstriction so the shell insulates the core, shivering which raises heat production three- to fivefold, nonshivering thermogenesis in brown fat through UCP1 principally in infants, piloerection which is vestigial in humans, and behavioural responses such as adding clothing and seeking warmth. If the body is too hot, heat-loss responses are activated: cutaneous vasodilation delivering up to eight litres per minute to the skin, sweating of up to one and a half litres per hour at zero point five eight kilocalories per millilitre evaporated, and behaviour such as seeking shade and removing clothing. Both arms alter core temperature, closing the negative feedback loop. Four physical routes carry heat out: radiation, about sixty percent, as infrared emission to cooler objects requiring no contact; convection, about fifteen percent, as moving air carries the heated boundary layer away; conduction, about three percent, by direct contact, rising roughly twenty-five-fold in water; and evaporation, about twenty-two percent, at zero point five eight kilocalories per millilitre of sweat actually evaporated. Evaporation is the only route that still works when ambient temperature exceeds skin temperature, and it is blocked by humidity, since sweat that drips off is wasted. In fever, pyrogens — bacterial lipopolysaccharide externally, and interleukin-1, interleukin-6, and tumour necrosis factor internally — raise prostaglandin E2 in the preoptic area and move the set point from thirty-seven to about thirty-nine degrees. The body then reads itself as too cold and correctly runs every heat-promoting response, producing chills and shivering, until it plateaus at the new set point. When the pyrogen is cleared or cyclooxygenase is blocked by an antipyretic, the set point returns to thirty-seven, the body reads itself as too hot, and the drenching sweat of the crisis follows. Nothing in the loop is broken; only the target changed.

When regulation fails

Hyperthermia. Heat exhaustion is a circulatory failure with intact thermoregulation: massive sweating and cutaneous vasodilation deplete plasma volume, the patient is weak, nauseated, tachycardic, and sweating heavily, and core temperature is usually below 40 °C. Heat stroke is thermoregulatory failure itself: core temperature above 40 °C, central nervous system dysfunction (confusion, seizure, coma), and classically — though not always — hot, dry skin, because sweating has ceased. The distinction is the presence or absence of a working effector, and it determines whether the treatment is rest and fluid or immediate aggressive cooling.

Malignant hyperthermia is a different mechanism worth knowing: an inherited RYR1 channel abnormality in which certain anaesthetic agents cause uncontrolled calcium release from the sarcoplasmic reticulum. Muscle contracts continuously and hydrolyzes ATP at an enormous rate; the heat is generated in the muscle itself, so it is a failure of production control rather than of the thermostat.

Hypothermia. Mild (32–35 °C): shivering, vasoconstriction, confusion. Moderate (28–32 °C): shivering stops — a critical sign, because the body has lost its main heat-generating effector — with bradycardia, dilated pupils, and progressive obtundation. Severe (below 28 °C): ventricular fibrillation risk, apparent death. Two clinical corollaries: hypothermia is markedly protective of the brain, so resuscitation is continued far longer than usual — "not dead until warm and dead" — and rewarming must be gradual, since sudden peripheral vasodilation returns cold, acidotic blood to the heart and can drop core temperature further, the afterdrop.

Development · Brown Fat and the Newborn Who Cannot Shiver

A newborn is a thermoregulatory problem in nearly every respect. It has a large surface area relative to its mass, thin subcutaneous fat, wet skin at delivery, and — critically — it cannot shiver effectively, because shivering requires muscle mass and coordinated motor control it does not yet have.

The solution is brown adipose tissue, which constitutes up to about 5% of a newborn's body mass and is deposited in the interscapular region, around the neck and great vessels, along the spine, and around the kidneys and adrenals — sited to warm blood as it returns to the core.

The mechanism is a controlled inefficiency. Brown adipocytes are packed with mitochondria whose inner membrane carries UCP1 (thermogenin), a proton channel. Normally the inner membrane is impermeable to protons, which is what makes chemiosmosis work (§24.4). UCP1 punches a hole in that impermeability: protons return to the matrix without passing through ATP synthase, so the energy of the gradient is released entirely as heat. Substrate oxidation runs at full speed producing almost no ATP. This is nonshivering thermogenesis, and it is switched on by sympathetic norepinephrine acting on β₃-adrenergic receptors — which is why brown fat is so densely innervated and so richly vascularized.

Brown fat regresses through childhood but does not vanish. FDG-PET scanning, performed for other reasons, repeatedly revealed metabolically active supraclavicular and paravertebral depots in adults, especially in winter and especially in lean individuals — a finding that has made brown fat activation an active target in obesity research. Note also the diagnostic nuisance this creates: cold patients light up their brown fat on PET, which can be mistaken for tumour.

Check Your Understanding 24.9

  1. A runner collapses on a humid 32 °C day with a core temperature of 41 °C. Explain why humidity, rather than temperature, was the decisive factor.
  2. Why do antipyretics work by inhibiting cyclooxygenase, and what does that tell you about the mechanism of fever?
  3. Immersion in 10 °C water causes hypothermia far faster than 10 °C air. Give the physical reason and name the route.
Show answers
  1. At an ambient temperature of 32 °C the skin is only slightly warmer than the air, so radiation, convection, and conduction move almost no heat; above about 35 °C they would move heat inward. That leaves evaporation as effectively the only cooling route. Evaporation depends on the vapour pressure gradient between wet skin and air, and high humidity collapses that gradient — the sweat is produced and simply drips off without vaporizing, which costs fluid and delivers no cooling. The runner had one working route and it was disabled.
  2. Fever is produced when pyrogens — bacterial products, and endogenous IL-1, IL-6, and TNF — raise PGE₂ in the preoptic area, which raises the hypothalamic set point. Aspirin, ibuprofen, and acetaminophen inhibit cyclooxygenase and therefore prostaglandin synthesis, so the set point returns to 37 °C. That an antipyretic works at the level of a signalling molecule in the hypothalamus, rather than by cooling the body, proves fever is a regulated set-point change and not a failure of temperature control — the same conclusion reached in Chapter 1 from the pattern of symptoms alone.
  3. Water conducts heat roughly 25 times better than air and, because it also moves, carries heat away by convection at the same time. The routes are conduction and convection; evaporation is unavailable underwater and radiation is negligible. This is why cold-water immersion is the fastest cooling method for heat stroke — the same physics, used deliberately.

24.10 Advanced Topic · Metabolic Syndrome, and Metabolism at Race Pace

Metabolic syndrome as a multi-organ disorder

Metabolic syndrome is diagnosed by any three of five criteria; Amara meets all five. But the criteria are a scoring convenience, not a mechanism. The mechanism is a coordinated failure of insulin signalling across several organs at once, each contributing its own abnormality:

Organ What fails What appears in the labs
Skeletal muscle GLUT4 translocation impaired; intramyocellular lipid metabolites (diacylglycerol, ceramide) interfere with insulin signalling Post-meal hyperglycemia; the earliest defect of all
Liver Insulin fails to suppress gluconeogenesis, yet remains sensitive for lipogenesis (SREBP-1c) — selective insulin resistance Fasting glucose 212; triglycerides 244; fatty liver
Adipose tissue Lipolysis not suppressed; storage capacity exceeded, so lipid is deposited ectopically in liver and muscle High free fatty acids; the source of the lipid that poisons the other tissues
Pancreatic beta cell Compensates by hypersecreting, then progressively fails Fasting insulin 27, then falling; glucose rises
Pancreatic alpha cell Loses suppression by insulin and glucose Inappropriately high glucagon, driving more hepatic glucose output
Gut Blunted incretin (GIP/GLP-1) effect Exaggerated post-meal glucose excursion
Kidney Raised SGLT2 expression reabsorbs more filtered glucose Glucose retained rather than excreted; the target of a modern drug class
Adipose macrophages Infiltrate expanded fat; secrete TNF-α and IL-6; adiponectin falls Chronic low-grade inflammation, raised CRP

Two ideas tie the table together. Lipotoxicity: adipose tissue has a finite safe storage capacity, and once exceeded, lipid is deposited where it does not belong — in liver, muscle, pancreas, and heart — where its metabolites directly impair insulin signalling. And selective hepatic insulin resistance explains what otherwise looks contradictory: how the same liver can be deaf to insulin's instruction to stop making glucose while obeying its instruction to make fat. The result is high glucose and high triglycerides at the same time, from one hormone and one organ.

Thread 3 · The Body Is Integrated

Amara's five metabolic syndrome criteria are not five diseases. Follow the causal arrows: visceral adiposity → unrestrained lipolysis and portal free fatty acid delivery → hepatic steatosis and selective insulin resistance → raised hepatic glucose output (criterion 5) and raised VLDL export (criterion 2) → CETP-mediated triglyceride transfer to HDL and accelerated HDL clearance (criterion 3). Meanwhile hyperinsulinemia promotes renal sodium retention and sympathetic activation, and the endothelial dysfunction that accompanies all of the above raises vascular resistance (criterion 4). And the waist itself is criterion 1.

One upstream lesion, five downstream numbers, each of which is separately named, separately targeted, and separately billed. This is the strongest argument in the book for reading a laboratory panel as a system rather than a list — and it is also why the interventions that address the upstream lesion, such as exercise and weight loss, improve all five criteria at once, while a drug that targets one number usually improves only that number.

Exercise metabolism, and what happened at mile 21

  THE SUBSTRATE CROSSOVER — FUEL MIX AGAINST EXERCISE INTENSITY
  ══════════════════════════════════════════════════════════════════════

  % of energy
  from each fuel
   100 ┤                                              ████████████
       │                                        ██████            CARBO-
    80 ┤                                  ██████                  HYDRATE
       │                            ██████
    60 ┤                     ▓▓▓▓▓▓█  ← CROSSOVER POINT ~60-65% VO2max
       │            ▓▓▓▓▓▓▓▓▓  ████       (where CHO overtakes fat)
    40 ┤     ▓▓▓▓▓▓▓      ████
       │▓▓▓▓▓         ████                                        FAT
    20 ┤          ████                    ▓▓▓▓▓▓▓
       │      ████                               ▓▓▓▓▓▓▓▓▓▓▓
     0 ┼──────┴────────┴────────┴────────┴────────┴────────┴──────
        REST   25%     40%      55%      70%      85%     100%
                        % of VO2max
                                 ▲
                          FATMAX ~45-65% VO2max:  the intensity at which
                          ABSOLUTE fat oxidation (g/min) is HIGHEST.
                          Note it is NOT the same as "highest % from fat",
                          which is at rest.

  ── WHY THE CROSSOVER HAPPENS ─────────────────────────────────────────
   1 Recruitment of TYPE II fibres, which are glycolytic
   2 EPINEPHRINE + Ca2+ + AMP all directly activate glycogen phosphorylase
   3 Rising glycolytic flux raises malonyl-CoA → INHIBITS CPT-1 →
     fatty acids cannot enter the mitochondrion
   4 Splanchnic vasoconstriction reduces FFA delivery from adipose
   5 Fat oxidation is simply SLOWER: max ~1.0-1.5 g/min vs
     carbohydrate ~4-5 g/min. Above a certain power, fat cannot keep up.

  ── THE ARITHMETIC OF THE WALL ────────────────────────────────────────
   TOTAL BODY GLYCOGEN                    ~500 g  ≈  2,000 kcal
     muscle ~400 g (private — no glucose-6-phosphatase)
     liver  ~100 g (exportable)
   MARATHON ENERGY COST  ≈ 1 kcal per kg per km
     58 kg runner x 42.2 km  ≈  2,450 kcal
     at ~80% VO2max, ~80% of that from CARBOHYDRATE ≈ 1,960 kcal

   ► The store is ~2,000 kcal.  The bill is ~1,960 kcal of carbohydrate.
   ► The marathon is roughly 20-25% LONGER than the glycogen store.
   ► 20-25% of 26.2 miles = 5-6 miles from the end = MILE 20-21.
   ► This is why "the wall" lands in the same place for almost everyone,
     regardless of talent: it is set by a ratio, not by fitness.

Figure 24.7 — The substrate crossover from fat to carbohydrate as exercise intensity rises, and the arithmetic that places "the wall" at mile 20–21 of a marathon.

Described: A graph plots the percentage of energy derived from fat and from carbohydrate against exercise intensity expressed as percentage of maximal oxygen uptake. At rest and at low intensities, fat supplies the majority of energy and carbohydrate the minority. As intensity rises the two curves converge and cross at the crossover point, roughly sixty to sixty-five percent of maximal oxygen uptake, beyond which carbohydrate dominates and approaches one hundred percent at maximal effort. A separate marker identifies Fatmax, roughly forty-five to sixty-five percent of maximal oxygen uptake, the intensity at which absolute fat oxidation in grams per minute is highest — which is not the same as the intensity at which the highest percentage comes from fat, which occurs at rest. Five reasons for the crossover are listed: recruitment of glycolytic type two fibres; direct activation of glycogen phosphorylase by epinephrine, calcium, and AMP; rising glycolytic flux raising malonyl-CoA, which inhibits carnitine palmitoyltransferase-1 and blocks fatty acid entry into mitochondria; splanchnic vasoconstriction reducing free fatty acid delivery from adipose tissue; and the intrinsically slower maximum rate of fat oxidation, about one to one and a half grams per minute against four to five for carbohydrate. The second panel gives the arithmetic of glycogen depletion. Total body glycogen is about five hundred grams or two thousand kilocalories, of which four hundred grams is in muscle and unavailable to the blood because muscle lacks glucose-6-phosphatase, and one hundred grams is exportable liver glycogen. A marathon costs roughly one kilocalorie per kilogram per kilometre, so a fifty-eight kilogram runner covering forty-two point two kilometres expends about two thousand four hundred fifty kilocalories, of which at eighty percent of maximal oxygen uptake roughly eighty percent, about one thousand nine hundred sixty kilocalories, comes from carbohydrate. Since the store is about two thousand kilocalories and the carbohydrate bill is about the same, the marathon is roughly twenty to twenty-five percent longer than the glycogen store will carry — and twenty to twenty-five percent of twenty-six point two miles is five to six miles from the end, which places the wall at mile twenty to twenty-one for almost everyone regardless of talent, because it is set by a ratio rather than by fitness.

Exercise & Sport · Carbohydrate Loading, Fuelling, and Fat Adaptation

Three interventions attack the arithmetic in Figure 24.7 from three different directions.

Carbohydrate loading — enlarge the tank. A taper in training combined with 8–12 g of carbohydrate per kg body mass per day for one to three days raises muscle glycogen from a normal 100–120 mmol/kg wet weight to 180–220 — a supercompensation of 150–200%. In Nia's case that is perhaps 700 additional kilocalories, worth roughly 8 kilometres. The cost: each gram of glycogen binds about 3 g of water, so successful loading adds 1–1.5 kg of body mass, which feels wrong and is not.

Fuelling during the race — refill while running. The SGLT1 ceiling from Chapter 23 sets the limit. Up to about 60 g/h of glucose alone; up to 90 g/h using a glucose–fructose combination that recruits GLUT5 as a second transporter; and 100–120 g/h in gut-trained elite athletes. Over Nia's 3 hours 22 minutes, 60 g/h supplies about 200 g, or 800 kcal — the difference between hitting the wall at mile 18 and hitting it at mile 21, or, with better execution, not hitting it at all.

Fat adaptation — change the fuel mix. Several weeks of a very low carbohydrate, high fat diet substantially raises peak fat oxidation, from roughly 1.0 to as much as 1.5 g/min. It is a real physiological adaptation. It is also, for marathon-pace racing, generally a net negative: it down-regulates pyruvate dehydrogenase, impairing the high-rate carbohydrate flux needed for the final surges; and fat oxidation costs roughly 8% more oxygen per unit of ATP than carbohydrate oxidation, so at a fixed VO₂max the achievable power falls. It is a rational choice for ultra-endurance events run well below the crossover point, and a poor one for a marathon run above it.

Exercise & Sport · The Two Insulin Sensitivity Effects, Acute and Chronic

Muscle takes up glucose by GLUT4, which sits in intracellular vesicles until something signals it to fuse with the plasma membrane. There are two independent signals that do this, and that is the single most therapeutically important fact in this chapter.

Pathway 1 — insulin. Insulin binds its receptor, the receptor autophosphorylates, IRS-1 is phosphorylated, PI3-kinase and Akt are activated, and AS160/TBC1D4 is inhibited, releasing GLUT4 vesicles to translocate. This is the pathway that fails in insulin resistance, principally at the IRS-1/PI3K step, where lipid metabolites such as diacylglycerol and ceramide interfere.

Pathway 2 — muscle contraction. Contraction raises intracellular Ca²⁺ and the AMP:ATP ratio, which activate CaMKII and AMP-activated protein kinase (AMPK). These converge on the same AS160 target from a completely different direction and translocate GLUT4 from a partly distinct vesicle pool. This pathway is entirely insulin-independent, and it is intact in insulin-resistant muscle.

The acute effect follows: a single bout of exercise moves glucose into muscle in a person whose insulin pathway does not work. And it does not stop when the exercise stops. For 24–72 hours afterwards, insulin sensitivity is measurably improved, for two reasons: glycogen has been depleted, and depleted glycogen powerfully activates glycogen synthase, creating a glucose "sink"; and AS160 phosphorylation persists well beyond the exercise itself.

The chronic effect is different in kind: repeated training increases total GLUT4 protein content, drives mitochondrial biogenesis through PGC-1α, increases capillary density, and reduces intramyocellular lipid metabolites — repairing the insulin pathway rather than bypassing it.

The practical translation for Amara is exact. A 40-minute walk today lowers her glucose today and tomorrow, before she has lost a gram of fat, by using a pathway her disease has not touched. Doing it most days rebuilds the pathway her disease has touched. Two mechanisms, two timescales, one behaviour — and it is why exercise is prescribed as a drug in type 2 diabetes, with a dosing interval (most days, because the acute effect decays in 24–72 hours) derived directly from the molecular biology.

Check Your Understanding 24.10

  1. Why does fat oxidation, expressed as a percentage of energy, peak at rest, while fat oxidation expressed in grams per minute peaks at moderate intensity?
  2. A cyclist consumes 120 g of glucose per hour and develops cramping and diarrhea. What happened, and what should she have done differently?
  3. Why does exercise lower blood glucose in type 2 diabetes but risk hypoglycemia in a person taking insulin?
Show answers
  1. Because they are ratios with different denominators. At rest, total energy expenditure is tiny, and almost all of it is met by fat — a high percentage of a small number. As intensity rises, total expenditure climbs steeply; fat oxidation also climbs in absolute terms, but carbohydrate climbs faster, so fat's share falls even while its rate rises. Absolute fat oxidation peaks around 45–65% of VO₂max (Fatmax) and then declines as the malonyl-CoA and delivery constraints bite. The distinction matters practically: training "in the fat-burning zone" because a machine reports a high percentage is optimizing the wrong quantity.
  2. She exceeded the SGLT1 transport ceiling, which saturates at roughly 60 g/h for glucose alone. The excess remained in the lumen, held water osmotically, and reached the colon where bacteria fermented it — producing gas, cramping, and osmotic diarrhea, plus a net fluid shift into the gut that worsens dehydration. She should have used a glucose–fructose mixture at roughly 2:1, which recruits GLUT5 as a second, unsaturated transporter and supports 90 g/h or more, and should have trained the gut at that intake beforehand.
  3. In type 2 diabetes, exercise recruits the contraction-activated, insulin-independent GLUT4 pathway while the person's own insulin secretion falls normally as glucose falls — so glucose is lowered but the counter-regulatory brake still works. In a person injecting insulin, the injected dose is fixed and cannot be reduced by the body: the insulin-dependent and contraction-dependent pathways add together while hepatic glucose output is simultaneously suppressed by the circulating insulin. The result can be a rapid fall into hypoglycemia, which is why insulin-treated patients are taught to reduce dose or add carbohydrate before planned exercise. Two pathways that are independently useful are dangerous when driven at once.

Chapter Summary

§24.1 Six nutrient classes; three yield energy — carbohydrate and protein at 4 kcal/g, fat at 9, alcohol at 7. Fat carries more because its carbons are more reduced. Essential nutrients are those the body cannot synthesize: nine amino acids and two fatty acids. The DRIs (EAR, RDA, AI, UL) serve different purposes, and the evidence supports dietary patterns and replacement rather than single-nutrient prescriptions.

§24.2 Fat-soluble vitamins (A, D, E, K) are absorbed with fat, stored, poorly excreted, and therefore potentially toxic; water-soluble vitamins are filtered and excreted, so they must be replenished and are rarely toxic. B₁₂ is the great exception, stored in the liver for 3–5 years. Minerals divide into major and trace and serve structural, electrochemical, and catalytic roles.

§24.3 Anabolism builds and consumes energy; catabolism breaks down and releases it. Catabolism is controlled oxidation: hydrogen and electrons are stripped from fuel onto NAD⁺ and FAD. ATP is a transfer molecule, not a store — a 100 g pool turned over 50–75 kg per day — made by fast, low-yield substrate-level phosphorylation and slow, high-yield oxidative phosphorylation.

§24.4 Glycolysis: cytosolic, anaerobic-capable, net 2 ATP + 2 NADH + 2 pyruvate. Pyruvate becomes acetyl-CoA (irreversibly), lactate, alanine, or oxaloacetate. The citric acid cycle yields 3 NADH, 1 FADH₂, 1 ATP, 2 CO₂ per acetyl-CoA. The electron transport chain and chemiosmosis convert those carriers to ATP at 2.5 and 1.5 apiece, for a total of 30–32 ATP per glucose at ~34% efficiency. Liver glycogen serves the blood because the liver has glucose-6-phosphatase; muscle glycogen serves only the muscle because it does not.

§24.5 Beta-oxidation yields ~106 ATP from palmitate. Ketone bodies are made when oxaloacetate is diverted to gluconeogenesis, and they are the only fat-derived fuel that crosses the blood–brain barrier. Because pyruvate → acetyl-CoA is irreversible, fat cannot become glucose. Four lipoproteins move lipid: chylomicron, VLDL, and LDL outward; HDL inward, in the only route by which cholesterol leaves the body.

§24.6 Transamination funnels twenty amino groups onto glutamate; oxidative deamination releases ammonia; the urea cycle detoxifies it at 4 ATP per urea. Carbon skeletons are glucogenic or ketogenic. Protein is the fuel of last resort because there is no storage protein, the nitrogen is expensive, and the cost is functional.

§24.7 Insulin runs the absorptive program (store); glucagon, epinephrine, cortisol, and growth hormone run the postabsorptive one (mobilize, and defend blood glucose for the brain). One hormone lowers glucose and four raise it, because hypoglycemia kills faster. In insulin resistance the switch sticks: the liver will not stop gluconeogenesis and adipose will not stop lipolysis, so the fasting program runs during the fed state.

§24.8 TEE = BMR (60–75%) + TEF (~10%) + activity + NEAT. BMR tracks fat-free mass above all. Indirect calorimetry measures expenditure from O₂ consumption; the RER reports fuel mix, 0.7 for fat and 1.0 for carbohydrate. Intake is regulated in the arcuate nucleus by leptin, insulin, and ghrelin, and weight is defended asymmetrically — falling leptin is a far stronger signal than rising leptin. BMI cannot see fat distribution, which is what predicts risk.

§24.9 Two-thirds of metabolic energy appears as heat, and thermoregulation manages it. The hypothalamic preoptic area compares core temperature against a set point and drives heat-promoting or heat-loss effectors. Heat leaves by radiation (~60%), convection (~15%), conduction (~3%), and evaporation (~22%) — and evaporation is the only route that works above skin temperature. Fever is a deliberate set-point elevation by PGE₂; hyperthermia and hypothermia are failures of the loop itself.

§24.10 Metabolic syndrome is a coordinated multi-organ insulin signalling failure with lipotoxicity and selective hepatic resistance at its centre. In exercise, fuel mix crosses over from fat to carbohydrate at ~60–65% of VO₂max, and because total glycogen (~2,000 kcal) falls about 20–25% short of a marathon's carbohydrate bill, "the wall" lands near mile 20–21 for almost everyone. Contraction translocates GLUT4 through an insulin-independent AMPK and Ca²⁺ pathway, which is why a single session lowers glucose in insulin-resistant muscle.

The Three Threads in Chapter 24

Structure → Function. Enzyme distribution is anatomy at the molecular scale, and it determines organ roles as decisively as gross shape does: glucose-6-phosphatase in the liver and not in muscle makes one an exporter and the other a private consumer; UCP1 in brown fat and nowhere else turns a mitochondrion from an ATP factory into a heater; the presence or absence of an LDL receptor decides whether a cell takes up cholesterol in a regulated way or a macrophage takes it up in an unregulated one.

Homeostasis. Plasma glucose is defended more aggressively than almost any variable in the body, by one lowering hormone and four raising ones, because the brain cannot store or substitute for it. Core temperature is defended by a second complete loop with two opposing effector arms. And body weight is defended by a third — asymmetrically, which is why losing weight and keeping it off are two different physiological problems.

Integration. Amara's five metabolic syndrome criteria are one lesion read five ways, and the organs implicated are the liver, muscle, adipose, pancreas, gut, kidney, and immune system. Nia's wall at mile 21 is set by an enzyme's absence in muscle, a transporter's capacity in the gut, and a hormone's action on adipose tissue. Neither story stays inside this chapter.


Case File 24 · Resolution

Question 1 — Why does the same glucose molecule produce a fasting glucose of 212 in Amara and 84 in Nia?

Because the glucose is identical and the switch that decides what happens to it is not.

In Nia, a meal raises portal glucose, the beta cell releases insulin, and the absorptive program runs (§24.7). Her liver takes up glucose, runs glycogenesis and lipogenesis, and — the critical step — switches off gluconeogenesis. Her muscle translocates GLUT4 to the membrane and takes up glucose for glycogen. Her adipose tissue translocates GLUT4, activates lipoprotein lipase to capture circulating triglyceride, and switches off hormone-sensitive lipase so lipolysis stops. Four hours later the meal is stored, insulin falls, and the postabsorptive program takes over cleanly. Fasting glucose 84; triglycerides 62; HDL 71.

In Amara, the signal is sent and not received. Her fasting insulin of 28 µU/mL proves the beta cell is working hard — this is a failure of the effector limb, not of sensing.

  • Her liver does not switch off gluconeogenesis, so it exports glucose all night into a bloodstream that already has too much. That, not her breakfast, is why she wakes at 212 mg/dL. A fasting glucose is a measurement of hepatic glucose output.
  • Her adipose tissue does not switch off lipolysis, so free fatty acids flood the portal vein continuously. The liver, which remains selectively insulin-sensitive for lipogenesis, re-esterifies them and exports them as VLDL — hence triglycerides of 244. CETP then exchanges that triglyceride into HDL particles, and triglyceride-rich HDL is cleared faster — hence an HDL of 38. Two abnormal numbers, one cause.
  • Her muscle does not translocate GLUT4 efficiently, so post-meal glucose has nowhere to go and stays in the blood. Her HbA1c of 7.4% is the integrated record of that.

The single sentence to keep: in insulin resistance, the postabsorptive program runs during the absorptive state. Both programs are on at once. That is why she can be simultaneously hyperglycemic (fasting program in the liver), hyperinsulinemic (fed signal being shouted), and hypertriglyceridemic (fed program in the liver's lipogenic arm). It is not three diseases. It is one broken switch, read at three points.

Question 2 — What ran out at mile 21, and why there?

Glycogen — specifically the glycogen in her running muscles, supplemented by whatever her liver could still export.

The arithmetic is in Figure 24.7 and it is unforgiving. Total body glycogen is about 500 g, or roughly 2,000 kcal, of which ~400 g is in muscle (private, because muscle lacks glucose-6-phosphatase) and ~100 g in liver. A marathon costs approximately 1 kcal per kilogram per kilometre: for Nia at 58 kg over 42.2 km, about 2,450 kcal. At marathon race pace she is running at roughly 80% of VO₂max — well above the crossover point of 60–65% — so about 80% of that energy must come from carbohydrate: roughly 1,960 kcal.

Store: ~2,000 kcal. Bill: ~1,960 kcal. Plus whatever she drank — at perhaps 40–50 g/h over 3 hours 22 minutes, another 500–700 kcal. The margin is thin, and it is thin in the same way for everybody, because both terms scale with body mass: a heavier runner stores more glycogen and also spends more energy per kilometre. The marathon is roughly 20–25% longer than the glycogen store will carry, and 20–25% of 26.2 miles is five to six miles from the finish. Mile 20 to 21. The wall is set by a ratio, not by fitness, which is exactly why elite and recreational runners report it in the same place.

Why her legs and not her lungs? Because glycogen depletion is a substrate limitation, not an oxygen limitation. Her cardiovascular system was fine. The muscle simply could not generate ATP fast enough: fat oxidation caps out around 1.0–1.5 g/min against carbohydrate's 4–5 g/min, so once glycogen is gone the muscle is restricted to a fuel that cannot support the required power. The legs feel like concrete because force production has become rate-limited by ATP supply.

And why did her heart rate fall? Because heart rate tracks power output, and her power output had dropped. Running 8:40 pace instead of 7:35 requires less oxygen, so cardiac output falls to match. This is diagnostic, and it is the detail that distinguishes glycogen depletion from overheating or dehydration, both of which cause heart rate to rise at a given pace (cardiovascular drift). A falling heart rate with a falling pace, in a runner who is trying as hard as she can, means the limitation is inside the muscle.

Question 3 — How does exercise improve insulin sensitivity before any weight is lost?

Because muscle has two independent ways to put GLUT4 into its membrane, and Amara's disease has broken only one of them.

Pathway one is insulin: receptor → IRS-1 → PI3-kinase → Akt → inhibition of AS160 → GLUT4 translocation. In insulin resistance, lipid metabolites accumulated inside the muscle fibre — diacylglycerol and ceramide — interfere at the IRS-1/PI3K step. That pathway is impaired.

Pathway two is muscle contraction. Contraction raises intracellular Ca²⁺ and the AMP:ATP ratio, activating CaMKII and AMPK, which converge on the same AS160 target from a completely different direction and mobilize GLUT4 from a partly separate vesicle pool. This pathway does not involve the insulin receptor, IRS-1, or PI3-kinase at any point. It is insulin-independent, and in insulin-resistant muscle it is intact.

So a 40-minute walk moves glucose out of her blood and into her muscle using machinery her disease never touched. And the effect outlasts the walk by 24–72 hours, for two reasons: contraction depletes muscle glycogen, and depleted glycogen strongly activates glycogen synthase, creating a glucose sink that keeps drawing glucose in; and the phosphorylation state of AS160 remains altered for many hours afterwards.

That is the acute effect, and it requires no weight loss because it is not about fat mass at all. The chronic effect is different in kind: regular training increases total GLUT4 protein content, drives mitochondrial biogenesis via PGC-1α, increases capillary density, and depletes the intramyocellular lipid metabolites that were blocking pathway one in the first place — so training does not merely bypass the broken pathway, it repairs it.

The dosing follows from the mechanism. Because the acute effect decays over 24–72 hours, exercise must be performed most days rather than concentrated into one long weekend session. This is a prescription written in molecular biology, and it is the reason exercise is considered first-line therapy for type 2 diabetes rather than an adjunct to it.


Systems Integration Case File · Entry 24

Entry 24 — Metabolic syndrome, fully assembled

Amara begins a supervised programme: 150 minutes per week of moderate activity split across five days, a shift-work eating plan that moves her largest meal to before her shift rather than after it, and referral to a dietitian. Metformin is continued and a GLP-1 receptor agonist is added. Nia, three weeks post-marathon, is used as the comparison case throughout the visit.

Your entry:

1 · ADD (2–3 sentences). State, with numbers, what metabolism contributes to Amara's picture. Name the single upstream lesion and the five criteria it generates.

2 · CONNECT (2–3 sentences). Link metabolism to at least two systems already in your file, stating the direction of causation each time. Consider: cardiovascular, digestive, endocrine, nervous, urinary.

3 · PREDICT (1–2 sentences). Amara's kidneys have not yet been examined in this book. Predict one specific renal finding you expect in Chapter 26, and give the mechanism.

Show answers

1 · ADD. Amara meets all five metabolic syndrome criteria — waist 96 cm, triglycerides 244 mg/dL, HDL 38 mg/dL, blood pressure 138/84 on treatment, fasting glucose 212 mg/dL with an HbA1c of 7.4% — and her fasting insulin of 28 µU/mL shows the beta cell is compensating, not failing. The single upstream lesion is insulin resistance with visceral adiposity: it raises hepatic glucose output (criterion 5), raises VLDL export (criterion 2), lowers HDL through CETP exchange (criterion 3), promotes renal sodium retention and sympathetic activation (criterion 4), and is measured directly at the waist (criterion 1).

2 · CONNECT. Metabolic → cardiovascular: hypertriglyceridemia with low HDL and hyperglycemia accelerated the atherosclerosis that produced her infarct, and hyperinsulinemia raises sympathetic tone and renal sodium retention, which raises blood pressure. Digestive → metabolic: the gut sets the rate at which glucose and fat are delivered, and her night-shift eating pattern delivers her largest load at the worst circadian point — while the GLP-1 agonist now added works through the incretin axis of Chapter 23. Nervous → metabolic: twenty years of circadian disruption raised cortisol, which drives gluconeogenesis and proteolysis and worsens insulin resistance directly at the receptor. Metabolic → digestive: metformin causes GI symptoms and impairs B₁₂ absorption, compounding the PPI she now takes for her ulcer.

3 · PREDICT. Expect a reduced glomerular filtration rate with albuminuria. Mechanism: chronic hyperglycemia glycates glomerular basement membrane proteins and causes efferent arteriolar constriction and glomerular hyperfiltration, which over years injures podocytes and produces protein leak and then scarring; hypertension delivers that pressure directly to the glomerulus; and her reduced cardiac output limits renal perfusion. Three separate insults, one organ — and the cardiorenal loop closes in Chapter 26.


Review

Level 1 · Recall

21.1 The net ATP yield of glycolysis, per glucose, is:

a) 2    b) 4    c) 30    d) 36

Answer

a — 2. Four ATP are produced by substrate-level phosphorylation but two are invested in the preparatory phase, giving a net of two, plus 2 NADH and 2 pyruvate. Option b is the gross yield; c is the total for complete aerobic oxidation of glucose; d is an older figure based on superseded assumptions about proton stoichiometry.

21.2 Which molecule is the final electron acceptor of the electron transport chain?

a) NAD⁺    b) pyruvate    c) oxygen    d) ATP synthase

Answer

c — oxygen, which combines with electrons and protons at complex IV to form water. This is the only place in the body oxygen is consumed, and it is why oxygen deprivation kills so fast: without an acceptor the chain backs up, NADH cannot be reoxidized, and ATP production collapses within seconds.

21.3 Muscle glycogen cannot raise blood glucose because muscle lacks:

a) glycogen phosphorylase    b) glucose-6-phosphatase    c) hexokinase    d) GLUT4

Answer

b — glucose-6-phosphatase. Glycogenolysis in muscle yields glucose-6-phosphate, which carries a charge and cannot cross the plasma membrane. Only the liver (and renal cortex) can remove that phosphate and release free glucose. Muscle has all of the other three listed proteins.

21.4 Which lipoprotein carries out reverse cholesterol transport?

a) chylomicron    b) VLDL    c) LDL    d) HDL

Answer

d — HDL. It collects cholesterol from peripheral tissues, including macrophage foam cells in plaque, esterifies it via LCAT, and delivers it to the liver for biliary excretion. The other three carry lipid outward. Since the only route out of the body for cholesterol is bile, HDL is the sole return path — which is the mechanistic content of "good cholesterol."

21.5 A respiratory exchange ratio of 0.70 indicates that the subject is oxidizing predominantly:

a) carbohydrate    b) fat    c) protein    d) ketone bodies

Answer

b — fat. Fatty acids are hydrogen-rich and oxygen-poor, so their oxidation requires proportionally more O₂ per CO₂ produced: palmitate gives 16 CO₂ for 23 O₂, a ratio of 0.70. Carbohydrate gives 1.00 because glucose consumes six O₂ and produces six CO₂; mixed protein oxidation gives about 0.82.

21.6 Which route of heat loss remains effective when ambient temperature exceeds skin temperature?

a) radiation    b) conduction    c) convection    d) evaporation

Answer

d — evaporation. Radiation, conduction, and convection all depend on a temperature gradient from body to environment, and they reverse when the environment is hotter, adding heat. Evaporation depends instead on a water vapour pressure gradient, which is why it still works — and why humidity, not temperature alone, determines whether a hot day is survivable.

21.7 The dominant hormone of the absorptive state is:

a) glucagon    b) cortisol    c) insulin    d) epinephrine

Answer

c — insulin, the only major hormone that lowers blood glucose. The other three all raise it and all belong to the postabsorptive or stress response. The four-to-one asymmetry reflects relative danger: hypoglycemia kills in minutes, hyperglycemia over years.

21.8 Which vitamin's deficiency causes megaloblastic anemia and irreversible spinal cord degeneration?

a) folate    b) B₁₂    c) B₁ (thiamine)    d) C

Answer

b — B₁₂. Folate deficiency causes the same megaloblastic anemia but no neurological disease, which is exactly why the distinction is clinically dangerous: giving folate alone corrects the blood picture in a B₁₂-deficient patient while subacute combined degeneration proceeds unnoticed. Thiamine deficiency causes beriberi and Wernicke–Korsakoff; vitamin C deficiency causes scurvy.

Level 2 · Comprehension

21.9 Explain, in terms of one specific reaction, why fatty acids cannot be converted into glucose.

Model answer

The pyruvate dehydrogenase reaction — pyruvate → acetyl-CoA + CO₂ — is irreversible; no enzyme runs it backwards. Fatty acid catabolism produces acetyl-CoA and nothing else, so to make glucose from fat the carbon would have to travel backwards through that step, and it cannot. Nor can it escape via the citric acid cycle: the two carbons entering as acetyl-CoA are exactly matched by the two leaving as CO₂ per turn, so no net carbon is added to the pool of gluconeogenic intermediates. The only exceptions are marginal — the glycerol backbone of a triglyceride, which is about 5% of its mass, and the propionyl-CoA from odd-chain fatty acids. The consequence is fundamental: in prolonged fasting the brain's glucose must come from protein until ketone adaptation reduces the requirement.

21.10 Why does the body store long-term energy as fat rather than as glycogen, and what is the trade-off?

Model answer

Two reasons compound. Fat yields 9 kcal/g against carbohydrate's 4, because its carbons are more reduced. And glycogen is stored hydrated, binding roughly 3 g of water per gram, while triglyceride is stored essentially anhydrous. Combining both effects, fat stores energy at something like six times the density per unit mass. A 70 kg person carrying 15 kg of fat holds about 135,000 kcal; storing the same energy as hydrated glycogen would add well over 100 kg.

The trade-off is accessibility. Glycogen can be mobilized almost instantly and can be catabolized anaerobically; fat mobilization is slower, requires transport, requires the carnitine shuttle, and is strictly aerobic, with a maximum oxidation rate of roughly 1.0–1.5 g/min against carbohydrate's 4–5. Fat is a large, slow tank; glycogen is a small, fast one. Nia's wall at mile 21 is precisely the moment the fast tank empties and the slow one cannot supply the required power.

21.11 Fever and heat stroke both raise core temperature. Explain why one is a functioning homeostatic mechanism and the other is a failed one, and why the treatments differ.

Model answer

In fever every component of the loop works. Pyrogens raise PGE₂ in the preoptic area and move the set point from 37 to, say, 39 °C. The hypothalamus then correctly detects that the body is below its (new) target and correctly runs the heat-promoting arm: vasoconstriction, shivering, chills, seeking warmth. Temperature rises to the new set point and is then defended there. The target changed; the machinery did not fail.

In heat stroke the set point is unchanged at 37 °C and the machinery has failed. The hypothalamus correctly detects overheating and correctly commands cooling, but effector capacity is exceeded or lost — sweating ceases, and core temperature rises without limit.

Hence the treatments. Fever responds to an antipyretic, which lowers the set point at its source by inhibiting cyclooxygenase; the body then does its own cooling. Heat stroke does not respond to antipyretics at all, because there is no elevated set point to lower — it requires immediate external cooling, ideally cold-water immersion, which substitutes for the failed effector. Giving an antipyretic for heat stroke wastes the only minutes that matter.

21.12 Explain why a person who loses 10% of body weight has to eat less than a person of the same weight who never lost any, in order to maintain that weight.

Model answer

Because body weight is defended, and the defence is asymmetric. Weight loss reduces fat mass and therefore leptin, and falling leptin is a powerful starvation signal to the arcuate nucleus: it disinhibits NPY/AgRP neurons and inhibits POMC/CART neurons, raising hunger and lowering energy expenditure. Measured expenditure after a 10% loss sits roughly 10–15% below what body composition alone predicts — adaptive thermogenesis — arising from reduced sympathetic tone, reduced thyroid hormone conversion, improved skeletal muscle efficiency, and a substantial fall in NEAT. Simultaneously ghrelin rises and satiety hormones fall, and these changes persist for years rather than resolving.

So the reduced-weight person is smaller and running a lower expenditure for that size, while being hungrier. This is not a failure of willpower; it is a regulated response to a signal the body interprets as famine, and recognizing it as physiology rather than character is the single most useful thing a clinician can tell a patient about weight maintenance.

Level 3 · Clinical Application

21.13 A patient with type 1 diabetes stops insulin for two days. Glucose is 520 mg/dL, pH 7.14, bicarbonate 8 mEq/L, and potassium 5.6 mEq/L. Explain each finding, and explain why the potassium will fall dangerously once treatment begins.

Model answer

Glucose 520: without insulin, muscle and adipose GLUT4 stays internalized so glucose is not taken up, while the liver runs unopposed glycogenolysis and gluconeogenesis. The cells are starving amid abundant fuel, which drives the response harder.

pH 7.14 and bicarbonate 8: with no insulin at all, lipolysis is completely unrestrained. Free fatty acids flood the liver, and because oxaloacetate is being consumed by gluconeogenesis, acetyl-CoA is diverted to ketone bodies. Acetoacetate and β-hydroxybutyrate are moderately strong acids; they titrate bicarbonate and produce a high anion gap metabolic acidosis. Kussmaul respirations are the respiratory compensation (Chapter 22).

Potassium 5.6 (high) despite total body depletion: acidosis and insulin deficiency both shift K⁺ out of cells — H⁺ enters cells and K⁺ exits to preserve electroneutrality, and insulin normally drives K⁺ inward via Na⁺/K⁺ ATPase. Meanwhile osmotic diuresis has been excreting potassium for two days, so total body potassium is markedly low while serum potassium looks normal or high.

Why it falls on treatment: insulin drives K⁺ back into cells, correcting acidosis removes the second shifting force, and fluid resuscitation dilutes what remains. Serum potassium can plummet within hours into life-threatening hypokalemia with arrhythmia. This is why potassium is replaced during treatment of DKA, often before the serum value is even low, and why insulin is withheld if the initial potassium is below about 3.3 mEq/L.

21.14 An 82-year-old is found at home in winter, confused, with a core temperature of 30 °C and no shivering. Explain the absent shivering, the confusion, and why rewarming must be gradual.

Model answer

Absent shivering is the ominous finding. Shivering is the principal heat-generating effector below thermoneutrality, but it fails below roughly 30–32 °C: hypothalamic function itself is depressed, neuromuscular transmission slows, and glycogen substrate is exhausted. Loss of shivering means the patient can no longer generate heat and will continue to cool unless warmed externally. Age compounds it — reduced muscle mass, reduced BMR, blunted vasoconstriction, minimal brown fat, and often medications that impair the response.

Confusion reflects the temperature dependence of enzyme kinetics and membrane transport: cerebral metabolic rate falls roughly 6–7% per degree Celsius, and synaptic function, Na⁺/K⁺ ATPase activity, and conduction velocity all decline together.

Why gradual rewarming: cold peripheral tissue is vasoconstricted, acidotic, and full of potassium. Warming the surface first dilates those vessels and returns cold, acidotic, hyperkalemic blood to a cold and electrically irritable heart. Core temperature can fall further — the afterdrop — and ventricular fibrillation can be precipitated. The correct approach warms the core (warmed humidified oxygen, warmed intravenous fluids, and in severe cases extracorporeal rewarming) with minimal handling. And because hypothermia is neuroprotective, resuscitation is continued far longer than usual: the patient is not dead until warm and dead.

21.15 A 55-year-old man drinks heavily, eats little for three days, and arrives with a glucose of 38 mg/dL, a lactate of 4.5 mmol/L, and mild ketosis. Explain all three, and state the order in which you would treat.

Model answer

Hypoglycemia at 38: after three days without food his liver glycogen is long gone, so blood glucose depends entirely on gluconeogenesis. Ethanol metabolism generates a large excess of cytosolic NADH, which drives pyruvate → lactate and oxaloacetate → malate, removing both key gluconeogenic substrates. Gluconeogenesis is therefore inhibited at the moment it is the only source of glucose.

Lactate 4.5: the same raised NADH/NAD⁺ ratio pushes the lactate dehydrogenase equilibrium toward lactate, and the lactate cannot be consumed by gluconeogenesis for the same reason.

Ketosis: he is fasting, so lipolysis and beta-oxidation are running; the high NADH also inhibits the citric acid cycle, so acetyl-CoA accumulates and is converted to ketone bodies — alcoholic ketoacidosis, typically with modest hyperglycemia absent and often with a normal or low glucose, which distinguishes it from DKA.

Order of treatment: thiamine before glucose. He is almost certainly thiamine-depleted, and thiamine pyrophosphate is the cofactor for pyruvate dehydrogenase; giving a glucose load consumes the last of it and can precipitate Wernicke encephalopathy. Give thiamine, then glucose and saline, then replace potassium, magnesium, and phosphate, watching for refeeding physiology. The sequence is dictated entirely by which enzyme needs which cofactor.

Level 4 · Integration and Synthesis

21.16 Amara and Nia eat the same 700 kcal meal of rice, chicken, and vegetables. Trace that meal's fate in each body, organ by organ, over the following six hours, and identify every point at which the two diverge.

Model answer

Shared, through absorption (Chapter 23). Starch is digested by salivary and pancreatic amylase to maltose, maltotriose, and α-limit dextrins, then by brush border disaccharidases to glucose, absorbed on SGLT1 and exported by GLUT2 into the portal vein. Protein is digested by pepsin and pancreatic proteases to amino acids and small peptides, absorbed on Na⁺-coupled carriers and PepT1, also into the portal vein. Fat is emulsified by bile, hydrolyzed by lipase, ferried by micelles, re-esterified, and exported as chylomicrons into the lacteal — bypassing the liver. Both women release GIP and GLP-1 from the gut before glucose reaches the systemic circulation.

First divergence — the beta cell. Both secrete insulin, but Amara secretes far more for the same glucose load, because she is compensating for resistant tissues.

Second divergence — the liver. In Nia, insulin suppresses gluconeogenesis and switches on glycogenesis; hepatic glucose output goes to essentially zero. In Amara, gluconeogenesis continues, so her liver adds glucose to a bloodstream already receiving it from the gut. Her liver simultaneously runs lipogenesis, because it remains insulin-sensitive for that arm, and exports VLDL.

Third divergence — muscle. Nia's muscle translocates GLUT4 and stores glucose as glycogen, and takes up amino acids for protein synthesis. Amara's GLUT4 translocation is impaired, so glucose remains extracellular.

Fourth divergence — adipose. In Nia, insulin activates lipoprotein lipase, which strips triglyceride from chylomicrons for storage, and inhibits hormone-sensitive lipase, so lipolysis stops. In Amara, lipolysis is incompletely suppressed, so free fatty acids continue to enter the portal circulation while dietary fat is arriving — a fed and fasted signal simultaneously.

Six hours later. Nia's glucose has returned to baseline, her muscle glycogen is topped up, her triglycerides have cleared. Amara's glucose is still elevated, her insulin is still high, her triglycerides are still rising, and her liver has added a further increment of fat. The same 700 kcal has been stored appropriately in one body and has accumulated in the wrong compartments in the other. Nothing about the food differed. Everything about the switch did.

21.17 A drug is proposed that uncouples oxidative phosphorylation — it makes the inner mitochondrial membrane leaky to protons. Predict its effects on weight, temperature, and survival, and explain why such a drug was actually marketed in the 1930s and then banned.

Model answer

Uncoupling dissociates substrate oxidation from ATP synthesis. Protons return to the matrix without passing through ATP synthase, so the energy of the gradient is released entirely as heat (§24.9 — this is precisely what UCP1 does in brown fat).

Weight: falls, and rapidly. Because ATP yield per unit of substrate collapses, the cell must oxidize far more fuel to meet the same ATP demand. Metabolic rate rises steeply, and stored fat is consumed. As a weight loss mechanism it is extremely effective, which is exactly the problem.

Temperature: rises, potentially without limit. All the extra energy appears as heat, and the heat is generated inside cells throughout the body rather than by an identifiable effector the hypothalamus can switch off. The thermostat has no way to oppose it: vasodilation and sweating address heat loss, and here the fault is uncontrollable heat production. This is functionally the same problem as malignant hyperthermia.

Survival: poor at any dose approaching efficacy. 2,4-dinitrophenol (DNP) was sold as a diet drug in the United States in the 1930s, produced substantial weight loss, and was banned in 1938 after deaths from hyperthermia, together with cataracts from a separate mechanism. It remains available illicitly and continues to kill, because the therapeutic window between "burns fat" and "cooks the patient" is essentially nonexistent — there is no antidote and no way to switch the uncoupling off.

The general lesson: the ~34% efficiency of oxidative phosphorylation is not an engineering defect waiting to be exploited. The 66% released as heat is already being used to keep you at 37 °C, and the coupling ratio is a regulated variable, not spare capacity. Physiologically, the body already possesses the drug — UCP1 in brown fat — and keeps it under tight sympathetic control in a small, well-vascularized tissue, which is exactly the safety architecture a systemic uncoupler lacks.

21.18 Both of Amara's problems in Chapters 23 and 24 were made worse by a treatment given for a problem in an earlier chapter. Construct both chains, identify what they have in common as a class of clinical problem, and propose a general principle for managing it.

Model answer

Chain 1. Coronary disease → stent → mandatory dual antiplatelet therapy → COX-1 inhibition removes the prostaglandin component of the gastric mucosal barrier and blocks platelet-dependent mucosal repair → gastric ulcer → chronic blood loss → iron-deficiency anemia → reduced arterial oxygen content → increased cardiac output requirement in a heart with reduced ejection fraction → worsening of the original problem.

Chain 2. Insulin resistance and type 2 diabetes → metformin, which reduces hepatic glucose output and is the correct first-line drug → metformin impairs B₁₂ absorption in the terminal ileum; and the proton pump inhibitor added for chain 1 removes the acid needed to free B₁₂ from dietary protein and to reduce dietary iron for absorption → B₁₂ and iron deficiency → anemia and, if unrecognized, neuropathy — the latter easily attributed to diabetic neuropathy and therefore never investigated.

What they share: in both, a correct treatment for one organ imposes a cost on a different organ through a mechanism that has nothing to do with the disease being treated, and in both the cost eventually feeds back onto the original problem. The intermediate organ — the stomach, the ileum — is not the target of any of the drugs and is not monitored by any of the tests ordered for the primary disease. The common class is iatrogenic multi-organ coupling, and the reason it is under-detected is that specialties are organized by organ while drugs are not.

A general principle. For every drug, ask not only what receptor it blocks but where else that receptor or pathway is doing something useful — COX-1 in gastric mucosa, acid in iron and B₁₂ absorption, the mevalonate pathway in CoQ10 synthesis. Then monitor the second site explicitly rather than waiting for it to declare itself. In Amara's case that means a PPI prescribed prophylactically with dual antiplatelet therapy, and B₁₂ and iron measured periodically on long-term metformin and acid suppression. The physiological content of that recommendation is entirely contained in Chapters 23 and 24; the failure it prevents is a failure of integration, not of knowledge.

Concept Map to Complete

Copy this onto blank paper and fill in every bracket from memory before checking.

                      THE TWO METABOLIC STATES
                                │
        ┌───────────────────────┴────────────────────────┐
   ABSORPTIVE                                     POSTABSORPTIVE
   hormone: [ _______ ]                     hormones: [ ______ ],
   instruction: [ _____ ]                   [ ______ ], [ ______ ],
        │                                   [ ______ ]
        │                                   instruction: [ ________ ]
        │                                        │
   LIVER   glycogenesis ON                  LIVER   [ ____________ ] ON
           gluconeogenesis [ ___ ]                  gluconeogenesis [ __ ]
           lipogenesis ON                           [ ____________ ] ON
   MUSCLE  GLUT4 → [ ________ ]             MUSCLE  burns [ ______ ]
   ADIPOSE LPL [ ___ ]                              exports [ ______ ]
           HSL [ ___ ]                                 and [ ______ ]
                                            ADIPOSE [ ________ ] ON
        │
        └──────────────► DEFENDED VARIABLE: [ _____________ ]
                         because [ _______ ] cannot store it,
                         cannot make it, and cannot burn [ _____ ]

   INSULIN RESISTANCE = the switch stuck in the [ ____________ ] position
      liver fails to stop [ _______________ ]  → glucose [ ___ ]
      adipose fails to stop [ ____________ ]   → TAG [ ___ ] → HDL [ ___ ]
      muscle fails to move [ ______ ]          → post-meal glucose [ ___ ]

   TWO ROUTES TO GLUT4 IN THE MEMBRANE:
      1  insulin → IRS-1 → [ ______ ] → Akt → AS160   [ BROKEN / INTACT ]
      2  contraction → Ca2+ and [ ____ ] → AS160      [ BROKEN / INTACT ]

Lab / Self-Exploration

  1. Measure your own thermoregulation. Take your oral temperature at 06:00, 12:00, 16:00, and 22:00 on one day. Plot the four values. You should see a swing of 0.5–1.0 °C with a trough in the early morning and a peak in late afternoon. Note that this is the rhythm night shift work inverts.
  2. Demonstrate evaporative cooling. Wet the back of one hand and leave the other dry, then wave both. Then repeat in a steamy bathroom. The difference between the two settings, not the two hands, is why humidity kills.
  3. Estimate your own TEE. Calculate BMR with the Mifflin–St Jeor equation (10 × weight in kg + 6.25 × height in cm − 5 × age + 5 for males, −161 for females), then multiply by an activity factor of 1.2 (sedentary) to 1.9 (very active). Compare the result with what you actually eat for three days, recorded honestly. Most people underestimate intake by 20–30%; notice whether you did.
  4. Find the crossover in yourself. Walk briskly for ten minutes and note that you can hold a full conversation — you are below the crossover point and burning substantially fat. Then run hard for two minutes and notice that speech becomes clipped. The "talk test" is a crude but genuine proxy for the ventilatory threshold, which sits near the crossover.
  5. Read a nutrition label as a physiologist. Take any packaged food and calculate the percentage of its energy from each macronutrient using 4/4/9 kcal per gram. Compare with the percentage-by-weight figures on the front of the package. The two usually differ dramatically, and understanding why is the whole point.
  6. Trace one atom. Pick a glucose molecule in the bread you eat. Write out, from memory, every location its six carbons could occupy 24 hours later — in CO₂, in muscle glycogen, in hepatic glycogen, in a triglyceride in adipose tissue, in a nonessential amino acid, in lactate. Then say which of those it can never return from as glucose, and why.

Key Terms

absorptive state · The roughly four-hour period after a meal during which nutrients enter the blood and insulin drives storage.

acetyl-CoA · The two-carbon intermediate at which carbohydrate, fat, and protein catabolism converge; the one-way door, since its formation from pyruvate is irreversible.

adaptive thermogenesis · The fall in energy expenditure below that predicted by body composition following weight loss; part of the body's defence of body mass.

anabolism · Energy-consuming synthesis of larger molecules from smaller ones.

arcuate nucleus · Hypothalamic region containing orexigenic NPY/AgRP and anorexigenic POMC/CART neurons; the integrating centre for appetite.

basal metabolic rate (BMR) · Energy expenditure of a resting, awake, fasted, thermoneutral person; determined chiefly by fat-free mass.

beta-oxidation · Mitochondrial pathway removing two carbons at a time from a fatty acid, yielding one FADH₂, one NADH, and one acetyl-CoA per cycle.

catabolism · Energy-releasing breakdown of larger molecules into smaller ones.

chemiosmosis · Synthesis of ATP driven by protons flowing back across the inner mitochondrial membrane through ATP synthase.

chylomicron · Intestinal lipoprotein carrying dietary triglyceride from lymph to peripheral tissues.

citric acid cycle · Mitochondrial cycle oxidizing acetyl-CoA to two CO₂ while producing three NADH, one FADH₂, and one ATP per turn.

conduction / convection / evaporation / radiation · The four physical routes of heat exchange; evaporation is the only one that works above skin temperature.

crossover concept · The shift from predominantly fat to predominantly carbohydrate oxidation as exercise intensity rises past roughly 60–65% of VO₂max.

essential nutrient · One the body cannot synthesize and that must therefore be eaten; nine amino acids and two fatty acids.

gluconeogenesis · Synthesis of glucose from lactate, glycerol, and glucogenic amino acids, in liver and renal cortex.

glucose-6-phosphatase · The liver enzyme, absent from skeletal muscle, that allows glucose to leave the cell; the reason liver glycogen serves the blood and muscle glycogen does not.

GLUT4 · The insulin-responsive glucose transporter of muscle and adipose tissue, also translocated by an insulin-independent, contraction-activated pathway.

glycogenesis / glycogenolysis · Synthesis and breakdown of glycogen.

glycolysis · Cytosolic, oxygen-independent conversion of glucose to two pyruvate; net 2 ATP and 2 NADH.

HDL · High-density lipoprotein; carries out reverse cholesterol transport from tissues to liver for biliary excretion.

insulin resistance · Failure of target tissues to respond to insulin, so the postabsorptive program continues during the absorptive state.

ketone bodies · Acetoacetate, β-hydroxybutyrate, and acetone; liver-made, water-soluble fat-derived fuels that cross the blood–brain barrier.

LDL · Low-density lipoprotein; delivers cholesterol to tissues and, when in excess, to the arterial intima where it drives atherosclerosis.

leptin · Adipocyte hormone signalling fat mass to the hypothalamus; its fall is a far more powerful signal than its rise.

lipogenesis / lipolysis · Synthesis and hydrolysis of stored triglyceride.

metabolic syndrome · The clustering of central adiposity, hypertriglyceridemia, low HDL, raised blood pressure, and raised fasting glucose, arising from a single upstream insulin signalling lesion.

NAD⁺ / FAD · Electron carriers that accept hydrogen from oxidized fuel and deliver it to the electron transport chain, yielding ~2.5 and ~1.5 ATP respectively.

NEAT · Non-exercise activity thermogenesis; the energy cost of fidgeting, posture, and incidental movement, variable by up to 2,000 kcal/day.

oxidative phosphorylation · ATP synthesis powered by electron transfer to oxygen; ~90% of the body's ATP.

postabsorptive state · The fasting period in which glucagon, epinephrine, cortisol, and growth hormone mobilize fuel and defend blood glucose.

respiratory exchange ratio (RER) · VCO₂ ÷ VO₂; 0.70 indicates fat oxidation, 1.00 carbohydrate, values above 1.00 non-metabolic CO₂ from buffering.

substrate-level phosphorylation · Direct transfer of phosphate from a substrate to ADP; fast, oxygen-independent, low-yield.

thermic effect of food (TEF) · The energy cost of processing food, ~10% of intake and highest for protein.

transamination · Transfer of an amino group to α-ketoglutarate, funnelling nitrogen from many amino acids onto glutamate.

UCP1 (thermogenin) · Brown adipose proton channel that uncouples the proton gradient from ATP synthesis, releasing energy as heat.

urea cycle · Hepatic pathway converting toxic ammonia to urea for renal excretion, at about 4 ATP per molecule.

vitamin, fat-soluble / water-soluble · A, D, E, and K are absorbed with fat, stored, and potentially toxic; B complex and C are excreted in urine and must be replenished.


Next: Chapter 25 · Body Temperature Regulation — where the two-thirds of fuel energy that this chapter accounted for as heat stops being a rounding error and becomes a quantity the body must actively balance, and where UCP1 turns out to be a thermostat rather than an inefficiency.